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ABSTRACT 
 
 
The major histocompatibility complex (MHC) is the strongest genetic risk factor 
for autoimmunity. It acts together with a corresponding TCR repertoire, yet, considering 
the extent of the repertoire’s diversity, how this imposes disease susceptibility on a 
population is not well understood. We address the hypothesis that shared or public TCR, 
those present in most individuals, modulate autoimmune risk. High resolution analyses of 
autoimmune encephalomyelitis-associated T-cell receptor chain (TCR showed 
preferential utilization of public TCR sequences, implicating them in pathogenesis. 
Disease-associated public TCR, when transgenically expressed in association with 
endogenously rearranged T-cell receptor chain (TCR, could further endow unprimed 
T cells with autoantigen reactivity. Enforced expression of two of six public but no 
private TCR further provoked spontaneous, early-onset autoimmunity in mice. These 
findings implicate public TCR in skewing repertoire response characteristics and 
autoimmune susceptibility, demonstrate how single TCR chains can bias autoantigen 
specificity, and suggest that subsets of public TCR sequences may serve as disease-
specific biomarkers or therapeutic targets. 
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CHAPTER 1.    INTRODUCTION 
 
 
T-cell Receptor 
 
 
T Lymphocytes 
 
A complete immune system involves different functional cell types, each of which 
plays a particular role during immune response. Among these cells, the lymphocytes 
occupy the central stage because they are the cells representing the specificity of immune 
response. T cells constitute a major division of lymphocytes, which express TCR on the 
cell surface. TCR is a heterodimer composed of two distinct chains, α and β or γ and δ. 
The α and β heterodimers make up 95% of T-cells, while the γ and δ heterodimers make 
up 5% of T-cells
1
. The αβ TCRs can be further divided into two sub-lineages based on 
their distinct cell surface co-receptors, CD4 and CD8. Here we just focus on CD4
+ 
T cells 
bearing αβ TCRs. CD4+ T cells tend to differentiate into different functional cell subtypes 
secreting their typical cytokines as a consequence of priming. For example, Type 1 helper 
T cell (Th1) mainly produces interferon gamma (IFN- Type 1 helper T cell (h2) 
produces interleukin 4 (IL-4), IL-5, IL-13, Th17 help cell produces IL-17 and regulatory 
T cell (Treg) produces transforming growth factor beta (TGF- and IL-10. 
 
 
T Cell Maturation 
 
Pluripotent stem cells in bone marrow give rise to the T lineage precursors, and T 
lineage precursors will travel from the blood to thymus for a serial of early maturation 
events. In the thymic cortex, T lineage progenitors appear as CD4
-
CD8
-
 double negative 
form. During this stage, TCR chain will first undergo rearrangement. If the 
rearrangement produces a productive TCR chain, it will pair with a surrogate  chain, 
pre-T, otherwise will lead to clonal deletion. Functional TCRchain rearrangement will 
be followed by a successful TCR chain rearrangement and expression of CD4 and CD8 
co-receptors for the next double positive stage. Somatic recombination events for TCR 
must be completed by the CD4
+
CD8
+ 
stage and the CD4
+
CD8
+
double positive population 
need to migrate to thymic medulla for further maturation. For positive selection, only the 
CD4
+
CD8
+
 T cells with TCRs capable of low-affinity binding to a self-peptide-MHC 
(pMHC) on thymic epithelial cells can receive a signal to survive, otherwise they will be 
neglected and undergo apoptotic death
2
. Cells that undergo positive selection process will 
begin to commit to either the CD4
+
 or CD8
+
 single positive lineage. Relatively, low-
affinity recognition of a self-pMHCI will lose CD4 and differentiate into CD8
+
 T cells, 
while higher-affinity recognition of a self-pMHCII will lose CD8 and develop into CD4
+
 
T cells
3
.  During the commitment stage, differential expression of the lineage associated 
transcription factors, as ThPOK or Runx3, will accompany the CD4
+
 helper lymphocyte 
or CD8
+
 cytotoxic T lymphocyte (CTL) function
4
. On the other hand, since the somatic 
recombination event is a totally random process, CD4
+
 or CD8
+
 T lymphocytes will by 
chance produce high-affinity TCR recognizing auto-antigens in the thymus. These cells 
 2 
will undergo an elimination process and induce apoptotic cell death, which is referred as 
negative selection. In alternative, some cells bearing high affinity TCR to self-pMHC will 
induce the Foxp3 transcription expression, which causes the cells to differentiate into a 
specific subpopulation, natural regulatory T cells (nTreg). The TCR affinity for self-
pMHC of Treg is considered at the high end of the positive selection range but at the low 
end of the negative selection range
5
, but Treg development is not well understood. 
 
 
TCR Structure 
 
The TCR is a disulfide-linked heterodimer. Each single chain is organized as 
immunoglobulin (Ig) chains, consisting of a variable N terminal and a conserved C 
terminal. Although TCR shares similar structural features as B-cell receptor (BCR), the 
mechanism of antigen recognition is totally different. In contrast to recognizing intact 
molecules, TCR recognizes a complex consisting of a peptide, which is derived by 
proteolysis of the antigen and presented on a class I (MHC-I) or class II MHC (MHC-II) 
molecule by an antigen-presenting cell (APC). 
 
The adaptive immune system will encounter a large variety of pathogen-derived 
antigens, which requires a corresponding TCR diversity. The TCR diversity is primarily 
localized to three complementarity determining regions (CDRs) on each chain. Among 
the six CDR loops, relatively conserved amino acids in the TCR CDR1 and CDR2 
regions, encoded by the germ line V gene, are often used to bind exposed areas of the 
MHC -helix.  However, CDR3 loops, made up at least partially of non-germ line 
encoded residues are hyper variety and are positioned to engage with MHC bound 
peptide directly. The contact induced by CDR1 and CDR2 imposes the usual diagonal 
mode of TCR binding on MHC. Meanwhile, this arrangement also allows flexibility in 
the pitch formed by CDR1 and CDR2, allowing the TCR to accommodate CDR3 loops 
and peptide ligands of different sequences and lengths and yet still bind the pMHC in 
approximately the same orientation. Characterization of CDR3 sequence variation 
therefore provides a good measure of TCR diversity in an antigen selected repertoire. 
 
 
MHC 
 
 
Historical Discoveries 
 
The adaptive immune system consists of two components: antibody mediated 
humoral immunity and T cell mediated cellular immunity. In contrast to antibodies 
engaging with intact antigens, T cells function through interacting with the cell surface 
bound small peptides via their heterodimer T cell receptors. The task of displaying cell 
surface bound peptides for recognition by T cells is mediated by classical major 
histocompatibility complex
6
.  
 
 3 
Studies about MHC associated immune response began from rejection of grafts 
and tumor transplantation more than seventy years ago
7-9
. MHC represents a special case 
as the immune responses are extraordinarily sensitive to the difference at the MHC. 
Discovery of MHC suggests a co-evolutionary development of the lymphocyte receptors 
which are somatically generated in the thymus, conferring them the ability to react well 
with the foreign MHC but no longer react with the host MHC
10
.  
 
 
MHC Structure 
 
Until recently, great than 400 genes are mapped to the human or mouse Mhc. The 
mouse Mhc is referred as H2 while in human it is referred as HLA (Human Leucocyte 
Antigen).  In most cases we specifically refer the “MHC” molecules to the class I MHC 
and class II MHC based on their structural and functional properties. Both classes of 
MHC are heterodimers with similar structures which composed of three domains, one -
helix/-sheet () superdomain that forms a peptide-binding site and two Ig-like 
domains. A fully assembled class I MHC molecule is composed of a polymorphic  
chain noncovalently attached to the nonpolymorphic 2-microglobulin (m). The 
peptide-binding cleft (12 domain) is formed by the heavy chain only, and the light 
chain subunit, 2-microglobulin associated with 3 of the heavy chain to stabilize the 
peptide binding. In contrast, a fully assembled class II MHC molecule is composed of a 
polymorphic  chain noncovalently attached to a polymorphic  chain and the peptide-
binding cleft is formed by two heavy chains (11). To present the peptide antigens on 
MHC molecules, a seven stranded -sheet forms the floor of the binding groove and the 
sides are formed by two long -helices. Polymorphic residues cluster within and around 
the binding groove provide variation in structural and chemical properties, which 
accounts for the specific peptide-binding motifs for each MHC molecules
11-13
. 
 
Although both MHCs form a vice-like groove with two flanking -helices and a 
-sheets formed floor, the peptide binding groove ends are quite open in class II MHCs, 
which allows them to accommodate longer peptides. Generally, 8 to 10-mers peptides 
were presented by class I MHCs, whereas 10 to 30 residues or longer peptides were 
presented by class II MHCs. The anchor residues of the peptide are buried in specificity 
pockets that differ from allele to allele
14,15
, leaving the upwarding amino acid side chains 
bulging out of the groove for a direct interaction with the TCR. Termini sequences of the 
long peptides may also extend out the binding grooves and contribute to the TCR 
interaction. 
 
 
MHC and T Lymphocytes 
 
MHC molecules convey their function and trigger T cell responses via binding the 
peptide antigens and presenting them for recognition by antigen-specific T lymphocytes. 
Class II MHCs present peptides that originate from proteolysis of extracellular antigens 
in endosomal-type compartments, whereas class I MHCs present peptides primarily 
derived from intracellular degradation of proteins in the cytosol. Recognition of MHC 
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molecules is T cell type restricted, as cytotoxic T cells preferentially engage with class I 
MHCs, whereas T-helper cells preferentially engage with class II MHCs. 
 
 
MHC and Autoimmune Diseases 
 
Not only for transplant acceptance and immune responsiveness, the MHC is also 
the principal genetic locus conveying risk for a number of human diseases. More than 40 
diseases have been linked to the MHC, many of which are autoimmune disease in 
nature
16-19
. Particular alleles of HLA class II loci, especially with DR and DQ are high 
risk alleles for autoimmune diseases
20
. For example, studies identify the association of 
the HLA-DRB1 locus in rheumatoid arthritis, as HLA-DR4 shared a common sequence 
motif within the DR chain, suggesting preferential antigen presentation of self-epitopes 
by these molecules
21
. In human type 1 diabetes, HLA genes are also thought to contribute 
as much as 50% of the genetic risk for type 1 diabetes. The disease incidence is 
significantly increased in patients with HLA-DR3-DQ2 and DR4-DQ8 haplotypes
22,23
. 
Studies also indicated the homozygosity for HLA-DRB1*15:01 increases the probability 
of developing multiple sclerosis ~7-fold24,25. In contrast, few non-MHC alleles impart 
more than a 1.2-fold increase in risk
26
. The precise mechanisms underlying the 
association of most of these diseases with the particular MHC haplotypes are not well 
understood. Differential binding of self-antigen ligands may be one manner through 
which MHC variants alter risk. However, even on a single cell, thousands of different 
antigenic epitopes can bind to single MHC specificity. Therefore large numbers of tissue-
restricted epitopes will associate with any MHC allele. As an alternative, MHC molecules 
have been hypothesized to primarily confer risk by modulating the selection and 
activation of pathologic effector and protective regulatory T cells
27,28
. 
 
 
MHC Bias Pre-immune TCR Repertoire 
 
Despite the lack of direct evidence, the hypothesis that TCRs are evolutionarily 
selected to react with MHC is rational. The TCR specificity on developing thymocytes is 
screened through positive and negative selection
29,30
. 
 
One model that MHCs bias the pre-immune T cell repertoire was proposed, from 
which a large number of CD4
+
CD8
+
 thymocytes failed positive selection and died by 
neglect due to a lack of MHC specificity
2
. In addition, CD4, CD8, MHC-I and MHC-II 
knockout mice were utilized to analyze for the pre-selection repertoire. Mice without 
CD4 and CD8 still developed normal number of T cells, however, some of the cells could 
be activated by foreign cells lacking MHC molecules. These results implicate that CD4 
and CD8 molecule is required for interacting with MHC during pre-selection stage, in 
effect forcing all selected T cells to have an affinity for MHC
31
. 
 
Another model was proposed from the experiments performed on mice with 
impaired negative selection. TCR and  chains expressed by the pMHCII-specific T 
cells from those mice contact MHC primarily with the germ line encoded CDR1 and 
 5 
CDR2 regions, suggesting a co-evolutionary selection of TCR V domain and MHC 
molecules. This finding implies that many pre-selection CD4
+
 CD8
+
 thymocytes are 
deleted because of their intrinsic MHC specificity of TCRs and the only cells survive are 
those with TCRs containing CDR3 that interfere with CDR1 and CDR2 mediated MHC 
binding
32
. 
 
Nevertheless, what we mentioned above doesn’t exclude the role of CDR3 in 
mediating the pre-immune repertoire. CDR1 and CDR2 regions are located in the germ 
line-encoded V domains whereas the CDR3 regions are generated by the random V(D)J 
somatic recombination, which is responsible for interacting with peptide directly. Some 
CDR3 were found to interfere with TCR-pMHC interaction and lead CD4
+
CD8
+
 T cell 
die by neglect, in contrast, other CDR3 attenuated the CDR1 and CDR2 mediated MHC 
binding and foster positive selection. Thus, the CDR1 and CDR2 domain of most TCR 
and  chains can produce intrinsic MHC reactivity, CDR3 domain will sterically interfere 
to varying degrees with this reactivity, producing a repertoire of TCRs with a wide 
spectrum of affinities for self-MHC. 
 
 
TCR Repertoire 
 
 
TCR Repertoire Diversity 
 
Similar to the rearrangement of Ig heavy and light chains, the diversity of TCR 
repertoire is generated from somatic recombination. The V(D)J somatic recombination 
introduces two types of diversity: combinatorial diversity and junctional diversity. A 
functional TCRαβ heterodimer is generated through randomly arrange different gene 
segments, which refers to variable (V), diversity (D) and joining (J) gene segments to a 
constant region (C) in the case of TCRβ chains, or V-J-C in TCRα chains. In the human 
TCR loci, there are 42 TRBV, 2 TRBD, 12 TRBJ, 43 TRAV and 58 TRAJ functional 
gene segments, whereas in mouse TCR loci, there are 35 TRBV, 2 TRBD, 12 TRBJ, 71 
TRAV and 51 TRAJ functional gene segments
33
. The lymphocyte specific V(D)J 
recombinase will recognize the conserved recombination signal sequences located 
adjacent to V,D,J exons, delete intervening DNA and ligate the segments. Therefore, the 
amount of combinatorial diversity is decided by the possible number of combinations of 
the germline V, J, D gene segment numbers. In addition, the combinatorial diversity is 
further enhanced by the juxtaposition of two different, randomly generated TCR and 
TCRchain. On the other hand, the largest contribution to the diversity is coming from 
junctional diversity, which involves removal or addition of nucleotides between VD, DJ, 
or VJ junctions. Removal of nucleotides by nucleases may lead to the generation of novel 
amino acid sequences or to out-of-frame nonfunctional products, while DNA polymerase 
mediated asymmetric breaks repair or TdT mediated nucleotide addition will generate 
non-germ line coded sequences
34
. 
 
 Theoretically, these events will produce a potential repertoire diversity of up to 
10
15
 different TCRs in mice
1
 and 10
18
 in humans
35
. Given that only ~3% of T cells will 
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survive after thymic selection, this leaves more than 10
13
 possible TCR diversity for mice 
and 10
16
 for humans in the periphery if the full repertoire could form
36
. However, the 
estimated numbers of T cell clonotypes are only about 10
6
 in mice
37
 and 10
7
 in humans
1
 
in the peripheral circulation, several orders of magnitude less than the theoretical 
maximal diversity.  
 
 
Public TCR Repertoire 
 
Unlike antibodies, which can engage antigens in highly variable manners, TCR 
heterodimers associate with pMHC in largely stereotypical orientations that require 
significant energy contributions from both the TCR and  chains6. Considering this, 
public TCR or  chains would not be expected to bias TCR recognition, as each public 
TCR or  chain may associate with a vast array of distinct  or  chains that contribute 
roughly equally to recognition. However, it has also been shown that certain TRAV and 
TRBV chains are preferentially employed in specific responses
38-41
. In some extreme 
cases, certain TCR sequences are broadly shared between individuals, and therefore can 
be referred to as a ‘public’ repertoire42-44. 
 
What is the underlying mechanism of TCR bias? Biased TCR repertoire may 
result from different factors. First, a number of analyses were performed on public CD8
+
 
T cell responses to persistent infections such as human HIV
45,46
, Epstein-Barr virus 
(EBV)
47,48
 and cytomegalovirus (CMV)
49-51
, suggesting chronic antigenic stimulation  
can impose the selective expansion of T cell clonotypes with optimal TCR structural 
features
49,51
 in immune responses. Nevertheless, chronic viral antigenic stimulation in not 
necessarily required for promoting biased TCR usage, since it is also found in acute viral 
infection
52-55
 or after immunization
39,56-59
. The other evidence of biased TCR usage was 
also be found associated with autoimmune disease such as multiple sclerosis
56,60,61
 and 
type 1 diabetes
62
 or alloreactivity
63
.  
 
The other events influencing the TCR bias may happen either in the pre-selected 
repertoire or during thymic selection.  A model of convergent recombination was 
proposed by Venturi et al., as a process whereby multiple recombination events 
‘converge’ to produce the same nucleotide sequence and multiple nucleotide sequences 
‘converge’ to encode the same amino-acid sequence. This process enables some TCR 
sequences to be produced more frequently than others during somatic recombination
44
. 
On the other hand, studies indicated that CDR1 and CDR2 domains of TCR V regions are 
‘hard-wired’ with an inherent propensity to recognize conserved features in the MHC -
helices, thymic selection may shape the TCR repertoire with intrinsic TCR reactivity to 
self-MHC. The consequence of this bias towards MHC can result in a preferential usage 
of certain V regions in the TCR repertoire
64,65
. 
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Treg Cells 
 
 
Treg Identification 
 
As we mentioned above, both positive and negative selection shape the pre-
immune TCR repertoire based on TCR affinities
66
. Besides that, a specialized lineage of 
CD4
+
 T cells with TCR affinities for self-MHC will differentiate into regulatory T cells. 
Tregs play an essential role in mediate peripheral tolerance
67,68
. Tregs derived from 
thymus are referred to as natural Treg cells (nTreg), whereas Tregs generated in 
secondary lymphoid organs by foreign antigen stimulation are referred as induced Tregs 
(iTreg)
69
. 
 
It was proposed more than 40 years that a distinct subset of T cells generated from 
thymus is responsible for immune suppression
70
. The first evidence came from mouse 
neonatal thymectomy studies, mice thymectomized on the third day after birth (d3Tx) of 
neonatal mice developed organ specific autoimmune disease. However, the autoimmune 
disease could be totally prevented by thymus transplantation between days10 and 15 of 
life. This observation suggests thymocytes may contain a subset of suppressor cells 
which are exported from the thymus later than autoreactive T-cells
71
. Furthermore, 
Sakaguchi and his colleagues identified and characterized this subset of suppressor CD4
+
 
T-cells their constitutively expressed CD4 and IL-2 receptor  chain (CD25)72,73. 
However, CD25 is highly expressed on both activated CD4 and CD8 T cells, 
compromising its usefulness as a Treg restricted marker
74
. A major advance in the study 
of Treg was derived from the discovery of a genetic mutation in humans, 
immnunodysregulation, polyendocrinopathy and enterophathy, X linked syndrome 
(IPEX). The mutation genetic locus encodes a forkhead winged-helix transcription factor 
family member Foxp3
75
. Similar as studies on scurfy mice, Foxp3-gene knockouts 
resulted in complete loss of Treg cells and severe autoimmune disease
76
. The most 
important thing is that expression of Foxp3 is specifically restricted to Treg lineage and 
required for Treg cell development in the thymus
74,77-80
. Foxp3-GFP knocked in mice 
were developed by Rudensky et al., permitting ready identification and isolation of 
Foxp3
+
 Treg by cell sorting
81
. Treg cells make up approximately 10%-15% of mouse 
CD4
+
 lymphocytes, and approximately 5%-10% of CD4
+
CD8
-
 thymocytes
74
.  
 
 
Treg Development Models 
 
The common view about Treg origin is that the majority of Tregs are generated in 
the thymus as a distinct T cell subpopulation, bearing with high-affinity TCR-peptide-
MHC interactions. Studies were conducted using several double transgenic mice models. 
When TCR transgenic mice bearing a TCR specific for a determinant (S1) derived from 
influenza hemagglutinin (HA) were crossed to mice expressing the HA transgene, the 
transgenic T cells developed a large portion of Tregs rather than deletion.  In contrast, 
thymocytes bearing TCRs with low affinity to S1 reduced the percentage of Treg, which 
suggested that the selection of Treg appeared to require a TCR with high affinity for self-
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pMHC
82-84
. But why only 50% of the exported thymocytes developed into Tregs rather 
than 100% in that mice model is not clear, implying there is a “niche” size for Treg cell 
development
85
. An alternative model for the differentiation for thymic Treg was proposed 
by van Santen et al.
86
. In experiments where the transgenic TCR was confronted with 
their specific pMHC ligand in the thymus, the percentage of Treg cells increased without 
a change in absolute numbers. Thus, selective survival might be an alternative 
explanation for Treg differentiation.  
 
Mature nTregs are emigrants from the thymus, however, it is not the only place 
for the generation of Foxp3
+
 Treg cells. In some extrathymic condition, Foxp3
+
 T cells 
can be induced from peripheral non-Treg cells, referred as adaptive Tregs or induced 
Tregs (iTregs), which acquire similar suppressor phenotype and function as nTreg
87
. In 
vivo, cell transfer experiment demonstrated that approximately 5% splenic CD4
+
CD25
- 
T 
cells were converted to CD4
+
CD25
+
 suppressor cells in RAG -knockout recipient mice 
which expressed transgenic antigens
88
. TGF- is a pivotal factor for Treg generation in 
vitro through triggering the Smad2/3 signal pathway
89
. In addition, the vitamin A 
metabolite retinoic acid (RA), which is produced by a subset of DCs in the gut-associated 
lymphoid tissue, is able to inhibit IL-6 mediated Th17 cell induction. In the presence of 
TGF-, RA facilitates the convention of Foxp3- T cells to Foxp3+ Treg cells90,91. 
Furthermore, low doses stimulation in sub-immunogenic conditions can induce Treg 
generation in the periphery particularly to self-components that do not lead to tolerance in 
the thymus
87,92
. That may explain why majority iTreg is generated in the gut-associated 
lymphoid tissue since it is enriched for commensal bacteria antigens, and CD103
+
 DCs, 
which serve as the main source for RA and TGF-93,94.  
 
 
Treg Repertoire 
 
How can Treg precursors commit to Treg lineage instead of negative selection if 
they possess high-affinity TCR-peptide-MHC interactions? By using GFP-Foxp3 knock-
in mice, Hsieh et al. was able to reveal the selection of T cells into the Treg lineage at the 
transition from DP to SP, indicating commitment of Treg lineage and negative selection 
at the same stage
95
. In addition, double transgenic mice model revealed that the 
proportion of regulatory T cells declined with decreased TCR affinity and the affinity 
range permissive for Treg development overlaps considerably with the range promoting 
negative selection
96
. However, Treg cell development is accompanied by deletion of T 
cells sharing the same TCR, and the relative proportions of cells undergoing either 
negative selection or commitment to Tregs change with the doses of agonist 
peptide/MHC
96
. These results suggest that Treg commitment may be due to other 
intrinsic and extrinsic factors besides TCR affinity. 
 
 What factors decide the commitment to Treg lineage instead of non-Treg lineage? 
TCR repertoire analysis has been applied on Foxp3 deficient mice. The same TCR as 
used by suppressive Treg cells in normal mice could be used by pathogenic autoimmune 
T conventional cells (Tconv), suggesting normal mice might have a population of self-
reactive Tconv that express the Treg self-reactive TCR repertoire
95
. Very few studies 
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have addressed in detail either the TCR repertoire of Treg or their antigen specificity due 
to the limitation of methods. TCR repertoire analysis has been shown great potential to 
compare the TCR repertoire between Treg and Tconv. TCR repertoire analysis in pre 
immune mice demonstrated that naturally arising Tconv and Treg cells share a portion of 
TCRs that, depending on the experimental model and evaluation method, varies from 
10%–42%97-99. Not only to investigate the TCR repertoire in thymus, has TCR 
repertoire analysis also been utilized to survey the interconvertion between Treg and 
Tconv repertoire at the loci of inflammation. In one diabetes model, only limited Treg 
and Tconv cell overlap was found in islets, suggesting that these cell types were not 
interconverting at the site of inflammation
100
. Meanwhile, Liu et al. performed repertoire 
analyses and functional assessments of isolated TCRs from TCR retrogenic mice 
immunized with MOG-EAE. The result demonstrated that that ontogenically distinct 
Treg and Tconv cell repertoires with convergent specificities for autoantigen respond 
during autoimmunity
101
. In addition, high-throughput sequencing and global analysis 
were further conducted on normal MOG-EAE mice, showing differences in sequence and 
physical characteristics distinguish Treg and Tconv TCR
102
. 
 
 
Experimental Autoimmune Encephalomyelitis (EAE) 
 
As the most predominant autoimmune disorder of the central nervous system 
(CNS), multiple sclerosis (MS) affects approximate 2.5 million people worldwide
103
. 
Over the last eighty years, scientists developed EAE models to elucidate the pathogenesis 
of the disease or to test new therapeutic approaches
104
. EAE is a demyelinating disease of 
the CNS, with T cell and macrophages dominating the inflammatory response, causing 
destruction of axonal myelin sheath in the CNS and further neuronal damage
105
. Disease 
is most commonly induced in susceptible mice strains by immunization with 
immunodominant epitopes of myelin proteins such as MBP1-9 (myelin basic protein)
106
, 
PLP139-151 (proteolipid protein)
107
, or MOG35-55 (myelin oligodendrocyte glycoprotein)
108
 
together with complete Freund’s adjuvant and pertussis toxin. Activated encephalitogenic 
T cells then infiltrate into the CNS and initiate disease. Mice usually develop an acute 
episode of paralysis following by a spontaneous resolution. The disease symptoms of 
EAE reflect the anatomical location of the inflammatory lesions, which is similar to MS. 
However, the pathology of MS is quite heterogeneous since abnormal CD4
+
 T-cells, 
CD8
+ 
T-cells, B-cells and activated microglia/macrophages are correlated for the lesion 
development in MS patients
105
. Though there is no single EAE model, which can mimic 
MS as a whole, this will not preclude the study about the self-limiting nature of this CNS 
disease model. Foxp3
+
 regulatory T cells (Treg) are the effective suppressors responsible 
for disease resolution a regulatory network capable of suppressing vigorous auto-reactive 
response
109-111
. This model therefore provides a good basis to investigate regulatory 
mechanisms in CNS autoimmune disease. 
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High-throughput Sequencing (HTS) 
 
The adaptive immune system generates a large pool of T cell clonotypes to fight 
against innumerous pathogenic antigens.  The germ line genome is limited in size, 
however, the immune system compensates this by introducing the V(D)J somatic 
recombination. Focused on TCR, the receptor diversity is focused on a small segment of 
the TCR and  chain genes, the CDR3 region, which directly engage with peptide-MHC 
complex
6
. On average, it is grossly estimated that there are 20 - 200 T cells for each 
single clonotype in the periphery
112
, however, the frequencies vary dramatically due to a 
cell’s specificity and immunologic history113. Analyses of the TCR repertoire may 
provide insight into the nature and dynamics of these immune responses
114-116
. 
Traditional sequencing method may no longer meet the needs to investigate TCR 
repertoire systematically due to low time cost efficiency and limited sample size
97,101
. 
Advances in high-throughput sequencing have enabled the development of a powerful 
new technology for probing the adaptive immune system
115,117
. First of all, high-through 
put immunosequencing allows millions T cell receptor sequences can be read in parallel 
from a single sample. The dynamics of an adaptive immune response, which is based on 
clonal expansion and contraction, can be monitored in real time at high sensitivity and the 
global properties of the adaptive immune repertoires can be studied. Second, the highly 
variable CDR3 regions, which serve as tag for TCR are pretty short (~15-60 nt), making 
them amenable to rapid interrogation. Third, HTS has been successfully employed in 
many global adaptive immune repertoire property analyses where there is immune 
compromise, suggesting a potential clinical utility. Those areas cover the aging immune 
system
118
, immunotherapy
119
 and autoimmune disease
120
, etc. On the other hand, public 
clonotypes are associated with human disease or common pathogens within a specific 
HLA context
121
. Identification of public clonotypes in patients provides a potential 
diagnostic application. 
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CHAPTER 2.    METHODOLOGY 
 
 
Mice and Materials 
 
 
Mice 
 
C57BL/6J (B6), B6.129P2-Tcrb
tm1Mom/J (TCRβ-/-), B6.SJL-Ptprca Pep3b/BoyJ 
(CD45.1) and B6.129P2-Rag1
tm1Mon
/J (Rag1
-/-
) mice were purchased from The Jackson 
Laboratory (Bar Harbor, ME). GFP-Foxp3 mice on a B6 background were obtained from 
Dr. A. Rudensky (NYU)
74
. Mice were bred under specific-pathogen-free conditions, and 
animal experiments were carried out in compliance with Institutional Animal Care and 
Use Committee guidelines. 
 
 
Monoclonal Antibodies 
 
Red blood cells were lysed prior to staining. Fc receptors were blocked with mice 
CD16/CD32 antibody specific for Fcγ R III/I (Miltenyi Biotec, San Diego, CA). Cell 
surface staining was performed for 20 min at 4°C in PBS containing 0.1% sodium azide 
and 2% (vol/vol) fetal bovine serum (FBS). Monoclonal antibodies (Ab) specific for CD4 
(clone RM4-5), CD8 (clone 53-6.7), TCRβ (clone H57-597), CD44 (clone 1M7), 
CD45RB (clone C363.16A), CD69 (clone H1-2F3), CD45.1 (clone A20) or CD45.2 
(clone 104) were from BD Biosciences (San Jose, CA). For intracellular staining, cells 
were first stained with surface markers, fixed, permeabilized and stained for intracellular 
Foxp3 (clone FJK-16s) with the Foxp3 Staining Buffer Set (eBioscience, San Diego, CA). 
For cytokine staining, cells were first treated with 1x Cell Stimulation Cocktail 
(eBioscience) at 37°C for 4 hr, stained for surface markers in the presence of 10 μg mL-1 
Monensin (eBioscience), followed by fixation and permeabilization and staining for IL-
17A (clone eBio17B7, eBioscience) and IFN-γ (clone XMG1.2, BD Biosciences). Flow 
cytometric analysis was performed on an LSRFortessa (BD Biosciences) and analyzed by 
using FlowJo software (Tree Star, Ashland, OR). 
 
 
High-throughput Sequencing 
 
 
EAE Immunization 
 
MOG35-55 peptide (MEVGWYRSPFSRVVHLYRNGK) was synthesized by St. 
Jude Hartwell Center for Biotechnology and HPLC purified prior to use. EAE was 
induced and scored as described
102
.  In brief, B6 mice were s.c. immunized with 100 μg 
of MOG35–55 peptide in complete Freund's adjuvant containing 0.4 mg Mycobacterium 
tuberculosis H37RA (Difco, Lawrence, KS). Two hundred nanograms of pertussis toxin 
(List Biological Laboratories, Campbell, CA) was administered i.v. on day 0 and day 2. 
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Clinical scoring was: 1, limp tail; 2, hind limb paresis or partial paralysis; 3, total hind 
limb paralysis; 4, hind limb paralysis and body or front limb paresis or paralysis; 5, 
moribund.  
 
 
Cell Isolation 
 
Mice were sacrificed by CO2 asphyxiation and the spleens, lymph nodes, thymi 
were removed and collected individually in 6cm diameter dishes. Cells from these tissues 
were squeezed through the 70μm nylon mesh by gently mashing with the rubber end of a 
plunger from a 3cc syringe. A single cell suspension was created and harvest into a 50ml 
conical tube. Usually red blood cells need to be lysed for splenic cells. 
 
For CNS tissue, the mice were anesthetized by intraperitoneal administration of a 
lethal dose of Avertin (0.5ml of 2.5%, Sigma-Aldrich, St. Louis, MO). After complete 
anesthetization, the mice were placed on a polystyrene board and pinned down. The mice 
abdomen and chest were opened. The right atrium of the heart was cut open, and a 271/2 
g needle was immediately inserted into the left ventricle slowly perfused with PBS. After 
PBS perfusion, the brain and spinal cord were gently collected. The CNS tissue was 
gently mashed through a 70μm nylon cell strainer with the rubber end of a plunger. The 
cell suspension was spun down at 1500 rpm for 10 minutes and resuspended in 15ml of 
37.5% Percoll (GE Healthcare Bio-Sciences, Piscataway, NJ). After centrifuging at 1500 
rpm for 10 minutes with soft break, supernatant was gently discarded. The cell pellets 
were washed with PBS and then spun down again. 
 
 
Cell Counting 
 
Cell numbers were automatically calculated by Beckman cell coulter. As an 
alternative, adequately diluted cell suspension was thoroughly mixed with trypan blue 
and read on hemocytometer chamber. The total number of live cells was counted in the 
four corner squares. The cell concentration per ml was calculated as following equation. 
 
Cells per ml = the average count per square x the dilution factor x 10
4
 
 
 
Cell Sorting  
 
T cells were isolated from spleen, CNS, and thymus as described. Splenic and 
CNS cells were stained with CD4 Ab and flow cytometrically sorted into CD4
+ 
GFP-
Foxp3
+
 (Treg) and CD4
+
 GFP-Foxp3
- 
(Tconv) populations. Some splenic Tconv cells 
were further sorted into CD4
+
CD44
hi
CD45RB
lo
 (memory/effector) and 
CD4
+
CD44
lo
CD45RB
hi
 (naïve) populations. Thymic T cells were stained with CD4, 
CD8, and TCR Abs and sorted into CD4
+
CD8
+
TCR
lo
 double positive, CD4
+
CD8
-
Foxp3
-
, 
and CD4
+
CD8
-
Foxp3
+
 single positive T cell populations. Flow cytometric sorting used a 
Reflection (Sony Biotechnology, Champaign, IL) sorter. 
 13 
 
 
RNA Isolation and cDNA Transcription 
 
Sorted cell populations were lysed, and total RNA was isolated using the RNeasy 
Kit (Qiagen, Valencia, CA). cDNA was produced using the Omniscript RT Kit (Qiagen) 
according to the manufacturer’s instructions. cDNA was amplified with C (5’-
GGGTGGAGTCACATTTCTCAGATC-3’) and Vb8.2 (5’-
CCCCCTCTCAGACATCAGTGTAC-3’) specific primers using the High Fidelity PCR 
System (Roche, Indianapolis, IN). The ~200-bp PCR product was purified by agarose gel 
electrophoresis and column purification (QIAquick Gel Extraction Kit, Qiagen). 
 
 
DNA Preparation and Sequencing 
 
DNA end repair was performed according to our previous protocol
102
. First, 
incubate the PCR products from cDNA transcription with 15U T4 DNA polymerase 
(NEB, Beverly, MA), 50U T4 polynucleotide kinase (NEB), 0.4 mM 2’-deoxynucleoside 
5’-triphosphate, 1x T4 ligase buffer with 10 mM 2’-deoxyadenosine triphosphate 
(Promega, Madison, WI), and 5U Klenow enzyme (Promega) for 30 min at 20°C. The 
product was subsequently purified by using the QIAquick PCR Purification Kit (Qiagen). 
To add adenosine tags on the DNA 3’ ends, purified DNA was incubated with 25U 
Klenow fragment (NEB), 1x Klenow buffer, and 0.2 mM 2’-deoxyadenosine triphosphate 
for 30 min at 37°C. The product was purified by using the MinElute Reaction Cleanup 
Kit (Qiagen) and concentrated to 10 ul volume. Next, sequencing adapters were ligated 
onto the DNA products, adding 3 mM Index PE adapter Oligo Mix, 5 ul Quick DNA 
ligase (NEB), and 1x ligase buffer, and incubated for 15 min at 20°C. To remove 
unligated adapters, the product was purified using the QIAquick Gel Extraction Kit 
(Qiagen). Samples were each divided into 3, and InPE 1.0 and 2.0 (Illumina®, San 
Diego, CA) and Index primers were next linked to the DNA, using the Phusion DNA 
Polymerase Kit (Finnzymes Oy, Eskoo, Finland) with the following PCR condition: 19 
cycles at 98°C 10 sec, 65°C 30 sec, 72°C 30 sec. The PCR products were purified using 
the QIAquick PCR purification kit, as above. Each sample was divided into 3, and 
equimolar quantities of each sequenced over three lanes of a flow cell with an Illumina® 
Genome Analyzer IIx sequencer using a 125 bp (plus 6 bp barcode) recipe to obtain 
single-end reads that cover the entire CDR3 region. 
 
 
Raw Data Trim 
 
Raw data was demultiplexed and filtered using CASAVA 1.6.0. The data was 
subsequently trimmed for the presence of adapter sequences using CLC Genomics 
WorkBench v4.0. The Illumina® 125-bp reads were then scanned for V and J 
sequence homology immediately external to the C and F residues bordering the CDR3 
using cross_match http://www.phrap.org/. To identify CDR3 sequences, reads were 
filtered based on the cross_match results using the following criteria: (i) 100% sequence 
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identity for both V and J mapping; (ii) translated amino acid sequence between V and 
J is in the correct frame and reveals a translated product (no stop codon); (iii) the 
deduced CDR3 amino acid sequences between the V and J sequences begin with the 
conserved C and end with a FGXG, FAXG or HGXG motif. The deduced CDR3 nt 
sequences were then scanned using the Phred quality score cutoffs of 0, 10, 20 or 30, and 
reads with CDR3 nt sequence containing at least one low quality base at a given cutoff 
level were filtered out 
 
 
Retrogenic Mice Models 
 
 
Molecular Subcloning 
 
The backbone construct is MSCV-IRES-GFP
122
, which was further designed for 
the sake of our experiments
101,123
. To generate the TCRβ1-GFP construct which expresses 
single TCR chain, the TRBV13-2+ TCR segment was PCR amplified from 
1MOG244.2
123
  (forward primer: 5’-
GCCGAATTCGCCACCATGTCTAACACTGCCTTC-3’; reverse primer: 5’-
GGGTAGCCAACTCGAGAATGAG-3’) and subcloned into EcoRI/XhoI sites in the 
IRES-GFP retroviral vector. The TCRβ1-CDR3-J segment was created by annealing a 
pair of complementary oligos synthesized by St. Jude Hartwell Center (sense oligo: 5’-
TCGAGTTGGCTACCCCCTCTCAGACATCAGTGTACTTCTGTGCCAGCGGTGAG
ACTGGGGGAAACTATGCTGAGCAGTTCTTCGGACCAGGGACACGACTCACCG
TCCTAGAA-3’; anti-sense oligo: 5’-
GATCTTCTAGGACGGTGAGTCGTGTCCCTGGTCCGAAGAACTGCTCAGCATA
GTTTCCCCCAGTCTCACCGCTGGCACAGAAGTACACTGATGTCTGAGAGGGG
GTAGCCAAC-3’). This was subcloned into the XhoI/BglII cloning sites of 1MOG244.2 
vector to synthetically recreate TCR1. Other TCRβ constructs were similarly 
constructed synthetically and the oligo sequences were in Table A-1. pMOTII plasmid 
(gift from Dr. D.Vignali; SJCRH) contained the entire OTII TCR (Vα2-2A-Vβ5.1) 
cassette. OTII TCRβ sequence was PCR amplified (forward primer: 5’-
GCCGAATTCGCCACCATGTCTAACACTGCCTTC-3’; reverse primer: 
GTCACATTTCTCAGATCTTCTAG-3’), digested with EcoRI/BglII, and then 
subcloned into the EcoRI/BglII sites of TCRβ1-GFP (Figure B-1a). 
 
To reconstitute a polycistronic MSCV construct expressing the unique TCRof 
1MOG244.2 and theTCRchain, 1MOG244.2 and TCRβ1-GFP constructs were both 
digested with EcoRI/XhoI. The digested fragment from 1MOG244.2, which included an 
entire TCRchain, a T. asigna 2A sequence and the TRBJ 13-2 segment, was ligated 
with the cut TCRβ1-GFP vector, generating a new plasmid named as 244.2-TCRβ1-
GFP (Figure B-1b). The other polycistronic constructs expressing different TCRchain 
but fixed TCRchain were reconstituted on 244.2-TCRβ1-GFP. The secondary 
BglII behind the CDR3was destroyed without disturbing the amino acid sequences by 
using Quick change site directed mutagenesis kit (Agilent Technologies, Santa Clara, 
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CA). Different TCRchains including TRAV and CDR3 were amplified and subcloned 
into the EcoRI/BglII cloning sites of 244.2-TCRβ1-GFP. 
 
 
Retroviral Transduction  
 
Retrovirus was produced as described
123
. Ten micrograms of retroviral construct 
and packing plasmid were cotransfected into 293 T cells using the calcium phosphate 
transfection method, and the cells were incubated in DMEM supplemented with 10% 
fetal bovine serum (Atlanta Biologicals, Lawrenceville, GA), 100 U mL
-1
 penicillin, 100 
µg mL
-1
 streptomycin, and 292 µg mL
-1
 L-glutamine (Invitrogen Life Technologies) at 
37°C for 36 hr. Supernatant was collected twice a day for 72 hr and used to infect 
GP+E86 retroviral producer cells in the presence of 8 μg ml-1 polybrene (Sigma-Aldrich, 
St. Louis, MO).  
 
 
Generation of Retrogenic Mice  
 
Donor TCRβ–/– mice received 0.15 mg 5-fluorouracil g−1 body weight i.p. (APP 
Pharmaceuticals, Schaumburg, IL). After 48 hr, bone marrow cells were harvested from 
the femurs of the mice and cultured in complete Click's medium (Invitrogen, Grand 
Island, NY) supplemented with 20% fetal bovine serum (FBS), 20 ng ml
−1 
mIL-3, 50 ng 
ml
−1 
hIL-6, and 50 ng ml
−1 
mSCF (Pepro Tech, Rocky Hill, NJ) for 48 hr. Next, the 
hematopoietic progenitor cells (HPCs) were collected and cocultured for another 48 hr 
with irradiated (1200 rads) GP+E86 retrovirus producer cells in complete Click's medium 
supplemented as above and with 6 μg ml-1polybrene. Then, the HPCs were harvested, re-
suspended in PBS supplemented with heparin (10 U per recipient mouse, Sigma-
Aldrich), and injected i.v. into the sublethally irradiated (450 rad) Rag1
-/-
 recipients at a 
ratio of two recipient mice per bone marrow donor. Transduction efficiency was 
confirmed by flow cytometry for GFP expression. Engraftment was analyzed on day 28 
after HPC transplantation. 
 
 
Clinical Evaluation  
 
Cohorts of retrogenic mice were generated and clinically monitored for ≥120 days 
after HPC transfer. Mice were processed and submitted for histopathologic examination 
either during the peak disease or after 120 days if healthy. Full necropsy including CNS 
tissues was processed on at least three mice for each cohort for concurrent inflammatory 
and degenerative lesions. Paraffin-embedded tissue samples were stained with 
hematoxylin and eosin (H&E) and, where appropriate, CD3. The severity of spontaneous 
EAE was scored by using the predetermined qualitative and semiquantitative criteria: 0, 
lesions absent, 1, minimal to mild inconspicuous lesions, 2, conspicuous lesions, 3, 
prominent multifocal lesions, 4, marked coalescing lesions. 
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Chimeric Mice  
 
HPCs from CD45.1
-
CD45.2
+
 TCRβ-/- mice were transfected with TCRβ1 
retrovirus as described above. Retrogenic HPCs were harvested and diluted with 
CD45.1
+
CD45.2
-
 syngeneic B6 bone marrow cells, and subsequently injected into 
irradiated (450Rads) CD45.1
+
CD45.2
-
 Rag1
-/-
 mice at a ratio of two recipient mice per 
bone marrow donor. Engraftment was analyzed at day 28 after HPC transplantation. 
Disease incidence was monitored for at least 60 days. 
 
 
Cell Proliferation Assay  
 
Splenic cells were isolated from retrogenic mice and CD4+ T cells were purified 
with anti-CD4 Ab (L3T4) coated microbeads (Miltenyi Biotec, San Diego, CA) and 
enriched using MACS separation columns (Miltenyi Biotec). Purified CD4+ T cells were 
co-cultured at 5 × 10
4
 per well in 96-well plates with 2 × 10
5
 irradiated (3500 rad) 
syngeneic splenic APCs and stimulated with 100 μg ml-1 MOG35-55 peptide for 72 hr, 
pulsed with 1 μCi 3H-thymidine (PerkinElmer, Boston, MA), and harvested 16 hr later 
for scintillation counting. To further assess the dividing cell fraction, the Cell Trace violet 
cell proliferation kit (Invitrogen) was used according to the manufacturer’s instruction. 
Cells were labeled with 5 μM CellTraceTM violet prior to culture with the indicated 
stimuli for 72 hr. The cells were then stained with surface markers and 7-AAD (BD 
Biosciences) and viable CD4 T cell proliferation was measured by dye dilution. As a 
positive control, 1 μL Mouse T-Activator CD3/CD28 Dynabeads (Invitrogen) were added 
to positive control wells to at a 1:1 bead-to-cell ratio. 
 
 
Cytokine Analysis  
 
Culture supernatants were collected at 48 hr and analyzed for IL-2, IL-4, IL-10, 
IFN-g, and IL-17A using the Milliplex MAP mouse cytokine/chemokine immunoassay 
kit (Millipore, Billerica, MA) on a Luminex (Bio-Rad) instrument. For intracellular 
cytokine staining, cells were cultured with 1x Cell Stimulation Cocktail (eBioscience) at 
37°C for 4 hr, stained for surface markers in the presence of 10 μg ml-1 monensin 
(eBioscience), followed by fixation and permeabilization, and intracellular staining with 
IL-17A and IFN- Abs. 
 
 
Retroviral Transfection of CD4
+
4G4 Hybridoma Cell 
 
Transfected GP+E86 retroviral producer cell lines were expanded in 75ml flasks. 
Twelve milliliter of retroviral supernatant was harvested from each day confluent 
GP+E86 producer cells. To transfect hybridoma cells, 1x10
6 
TCR-deficient CD4
+
 4G4 
hybridoma cells
101
 were resuspended in 3 ml retroviral supernatant in the presence of 6μ
g/ml polybrene. The cell suspension was centrifuged at 1800 rpm, 8°C for 90 minutes. 
The infected cells were then cultured at 37°C for 48hrs and cytometrically sorted twice 
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for the GFP
high
TCR
high
 population and expanded. The purity of the GFP
high
TCR
high
 4G4 
cells was confirmed by flow cytometry (BD FACSCalibur). 
 
 
Enzyme-linked Immunosorbent Assay (ELISA) 
 
In 96 well flat bottom plates, 1x10
5
 hybridoma cells were co-cultured with 3 x 10
5
 
(3500 rad) irradiated syngeneic splenic APCs in the presence of  indicated stimuli for 24 
hr. Purified CD3 antibody was pre-mounted in positive control wells. Culture supernatant 
was harvested for IL-2 ELISA assay (BD PharMingen). Purified anti-IL-2 capture 
antibody (clone MQ1-17H12) was diluted to 2μg/ml in binding solution. 100 μl of the 
diluted antibody solution was added per well of a 96-well ELISA plate (Nunc Maxisorb). 
The plate was sealed and incubated overnight at 4°C. The capture antibody solution was 
discarded, and non-specific binding was blocked by adding 200μl of blocking buffer per 
well (BD Bioscience), and incubated at RT for at least 2hrs. After wash with PBS/Tween 
(PBS and 0.1% Tweens) for 3 times, 100μl of culture supernatants were added to the each 
sample well, meanwhile a series of nine 2-fold dilutions of recombination mouse IL-2 
standard (from 5000pg/ml to 19.5pg/ml) was added to standard curve wells. The plate 
was sealed and incubated at 4°C overnight. After washing with PBS/Tweens for 4 times, 
100μl diluted biotinylated anti-IL-2 detection antibody (1μg/ml) was added and incubated 
at RT for 1 hour. Again after washing with PBS/Tween for 4 times, 100μl diluted 
peroxidase labeled anti-biotin (Vector laboratories, Burlingame, CA) was added and 
incubated at RT for 30 minutes. The plate was washed for 5 times and 100ul of ABTS 
substrate solution with hydrogen peroxide was added for color development. After color 
developed for 5-10 min, the optical density value was read on a microplate reader 
instrument (Bio-Rad) setting to 405nm. 
 
 
5’RACE 
 
T cells were isolated from the CNS of TCRβ1 retrogenic mice with disease scores 
≥ 3. RNA was isolated and 5’ RACE performed using the 5'/3' RACE Kit, 2nd 
Generation (Roche, Indianapolis, IN) following the manufacturer’s instructions. Briefly, 
full strand cDNA was synthesized from mRNA by using specific primer 1 (5’-
GGAGTCAAAGTCGGTGAACAG-3’). The mRNA template was degraded by 
Transcriptor Reverse Transcriptase. PolyA was added to the 3’ end of the cDNA, and the 
tailed cDNA was PCR amplified using the Oligo (dT) anchor primer (5’-
GACCACGCGTATCGATGTCGACTTTTTTTTTTTTTTTTV-3’) and a nested specific 
primer 2 (5’-CCTGAGACCGAGGATCTTTTAAC-3’). A second PCR reaction was 
performed with the PCR anchor primer (5’-GACCACGCGTATCGATGTCGAC-3’) and 
a nested specific primer 3 (5’-CAGGTTCTGGGTTCTGGAT-3’). PCR products were 
subsequently cloned with TOPO TA (Invitrogen). Bacterial clones were randomly 
selected for Sanger sequencing, and sequences identified using the IMGT database 
(http://www.imgt.org/).  
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Statistics 
 
Means and SDs were calculated in Excel or PRISM. Plots demonstrate mean ± 1 
SD. Two-tailed student t-tests were applied to compare any two groups and ANOVA for 
three or more groups. For multiple comparisons, significance is only shown for indicated 
groups. A p < 0.05 was considered statistically significant. Kaplan Meier curves were 
calculated in PRISM.  
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CHAPTER 3.    RESULTS 
 
 
Introduction 
 
Despite the theoretical diversity of the TCR repertoire, a small fraction of  and  
monomers are shared by most individuals, or public
42,44
. Public TCR largely result from 
recombinatorial biases in TCR  and  chain formation, and in some studies were found 
to be prevalent in autoimmune and other responses
43,124-126
. Unlike antibodies, which can 
engage antigens in highly variable manners, TCR heterodimers associate with pMHC 
in largely stereoptypical orientations that require significant energy contributions from 
both the TCR  and  chains6. Considering this, public TCR  or  chains would not be 
expected to bias TCR recognition, as each public  or  may associate with a vast array 
of distinct  or  chains that contribute roughly equally to recognition. However, it has 
also been shown that certain TRAV and TRBV chains are preferentially employed in 
specific responses
38-41, and in one case structural data identified a binding “hotspot” 
between a single TRBV and antigen-MHC ligand explaining this preference
124
.  
 
Considering this, we hypothesized that public  or  chains, which are fixed not 
only for the V region, but for J and CDR3 sequences may modulate a TCR 
heterodimer’s likelihood of productively engaging autoantigen. Because public TCR 
chains are shared throughout a population and, due to their preferential formation, often 
present at high frequency
127
, they may in theory also broadly influence autoimmune 
susceptibility.  
 
Here we use a model of CNS autoimmune disease, experimental autoimmune 
encephalomyelitis, to identify the role of public TCR chains in disease susceptibility, 
coupling high-throughput analyses of the TCR repertoire with functional studies and the 
transgenic expression of 15 disease-associated public and private TCR. Analyses of >18 
million TCR from Foxp3+ regulatory and Foxp3- conventional T cells from different 
organs and time points identified a high prevalence of public TCR within the 
autoimmune response, consistent with previous lower resolution analyses in other 
models.  
 
 
Results 
 
 
High Prevalence of Public TCR in the Autoimmune Repertoire 
Demographic information of the sequenced TCRrepertoires 
 
To understand the composition and dynamics of autoimmune effector and 
regulatory repertoires, we analyzed CD4
+
 Foxp3
-
 (Tconv) and Foxp3
+
 (Treg) TRBV13-2
+ 
TCR in mice with myelin oligodendrocyte glycoprotein (MOG)35-55-induced EAE and 
healthy controls. TRBV13-2 is the dominant TCR in MOG-specific T cells128. 
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Saturation sequencing was performed using high-throughput techniques, with >18x10
6
 
TCR studied
43,102,117,129,130
, either from control mice (Table 3-1), EAE immunized mice 
with early disease (Table 3-2) or EAE immunized mice with late disease (Table 3-3). 
TRBJ utilization 
 
TRBJ utilization, an indicator of the heterogeneity of the sequenced populations, 
was compared in Tconv and Treg from the CNS and spleens of mice with EAE and 
spleens of controls and analyzed by one-way ANOVA. The results demonstrated that 
TRBJ utilization was diverse and similar among these sample groups, not matter the 
comparison was for unique sequences, which represented clonotype diversity, or total 
sequences, which represented both diversity and abundance. Only a slightly increased 
frequency for TRBJ 2.1 usage was seen in Tconv and Treg from the CNS with early EAE 
(Figure 3-1). 
CNS infiltrating TCR repertoires mapped onto splenic TCR repertoire 
 
When we performed routine phenotypic staining on the CNS infiltrating T cells, 
we found the majority of CNS infiltrating Tconv cells had activated, memory/effector T 
cell phenotype with high level CD69 and CD44 expression.  Therefore we tried to trace 
the cell origin by comparing the TCR repertoires of CNS Tconv cells with the splenic 
memory and naïve TCR repertoires. The results demonstrated that the splenic sequences 
identified in the CNS were heavily biased toward the memory/activated subset 
(77.7±9.0% of unique, 99.0±0.7% of total TCR sequences acquired) (Figure 3-2), 
indicating that the CNS was infiltrated by highly diverse, activated T cell populations 
from the periphery. 
Over representation of shared TRBV13-2
+
 TCR among CNS-infiltrating T 
cells 
 
Due to the limited size of the CNS infiltrates, relatively small numbers of unique 
sequences were identified in the CNS repertoires (Table 3-2 and Table 3-3). Of these, 
9.2% of the unique Foxp3
-
 CNS sequences present in mice with early EAE (d 15-18) 
were shared by ≥2 of 9 mice (Figure 3-3a). However, the shared sequences comprised 
50.8% of total CNS sequences acquired, indicating a high prevalence of the shared 
TCR. Similarly, in 3 mice analyzed with late disease (d 26), 8.1% of unique sequences 
were shared, but these comprised 49.6% of total CNS Foxp3
-
 sequences (Figure 3-3d). 
Progressively smaller numbers of unique Foxp3
-
 TCR were shared in the CNS by 
increasing numbers of mice (Figure 3-3b, e).  Meanwhile, we noticed the shared TCR 
had a pattern to be over-represented due to clonal expansion. For example, 0.05% of 
unique CD4
+
 Foxp3
-
-derived TCRsequences were identified in ≥7 of the 9 early EAE 
CNS, but comprised >1.5% of total sequences acquired. Therefore, we calculated the 
frequency of identification of each unique amino acid sequence relative to that of an 
average sequence in the same CNS. The representation ratio increased along with the 
increasing number of shared mice, suggesting these shared TCR were heavily utilized 
(Figure 3-3c, f). A similar pattern of high shared TCR representation was evident with 
CNS-infiltrating Treg cells (Figure 3-3g-l). 
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Table 3-1. Description of TRBV13-2
+
 TCR sequences acquired from control 
mice. 
 
Mouse Organ Cell type Total 
sequences 
acquired 
Unique 
CDR3 aa 
sequences 
acquired 
Unique 
CDR3 nt 
sequences 
acquired 
1 Spleen Foxp3
-
 281,344 73,570 106,280 
 Spleen Foxp3
+
 440,281 23,277 29,429 
2 Spleen Foxp3
-
 62,062 27,752 36,092 
 Spleen Foxp3
+
 111,605 14,542 17,415 
3 Spleen Foxp3
-
 290,060 66,792 94,807 
 Spleen Foxp3
+
 270,998 19,853 24,702 
 Thymus CD4+CD8
+
TCR
lo
 256,784 61,634 76,304 
4 Spleen Foxp3
-
 438,870 52,958 74,596 
 Spleen Foxp3
+
 351,528 24,441 31,038 
 Thymus CD4+CD8
+
TCR
lo
 393,817 75,945 95,070 
5 Thymus CD4+CD8
+
TCR
lo
 216,474 47,159 58,864 
6 Thymus CD4+CD8
+
TCR
lo
 280,972 52,659 65,831 
Splenocytes were flow sorted for CD4, TCR and GFP-Foxp3 as indicated. The 
CD4
+
CD8
+
TCR
lo
 thymic population was CD5 and CD69 negative, indicative of a pre-
selection population. Numbers listed are of sequences available for analysis after culling 
based on sequence quality metrics. 
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Table 3-2. Description of TRBV13-2
+
 TCR sequences acquired from mice with 
early EAE. 
 
Mouse EAE 
day 
Disease 
score 
Organ Cell type Total 
sequences 
acquired 
Unique 
CDR3 aa 
sequences 
acquired 
Unique 
CDR3 nt 
sequences 
acquired 
1 15 3 CNS Foxp3
-
 156,144 2,874 3,421 
   CNS Foxp3
+
 87,181 4,132 4,713 
   Spleen Foxp3
-
 63,835 29,305 38,439 
   Spleen Foxp3
+
 24,836 6,735 7,580 
2 15 3 CNS Foxp3
-
 46,981 2,449 2,728 
   CNS Foxp3
+
 49,642 1,439 1,658 
   Spleen Foxp3
-
 97,675 37,439 52,648 
   Spleen Foxp3
+
 867,145 18,941 24,258 
3 16 3 CNS Foxp3
-
 103,407 3,513 3,999 
   CNS Foxp3
+
 82,018 2,664 3,138 
   Spleen Foxp3
-
 77,028 30,955 39,967 
   Spleen Foxp3
+
 71,488 11,741 13,828 
4 16 3 CNS Foxp3
-
 186,996 3,497 4,041 
   CNS Foxp3
+
 264,020 3,417 4,189 
   Spleen Foxp3
-
 388,207 55,115 78,185 
   Spleen Foxp3
+
 53,833 6,701 7,545 
8 18 3 Spleen Foxp3
-
 380,377 50,920 70,037 
   Spleen Foxp3
+
 421,907 17,770 22,336 
9 18 2 Spleen Foxp3
-
 327,583 62,579 89,502 
   Spleen Foxp3
+
 315,408 15,389 19,027 
10 15 3 CNS Foxp3
-
 274,619 2,687 3,506 
   CNS Foxp3
+
 87,560 2,240 2,628 
   Spleen CD45Rb
hi
CD44
lo
Fo
xp3
-
 
304,477 41,969 57,395 
   Spleen CD45Rb
lo
CD44
hi
Fo
xp3
-
 
39,229 4,961 5,527 
   Spleen Foxp3
+
 310,883 11,828 14,484 
11 15 4 CNS Foxp3
-
 591,007 1,700 2,261 
   CNS Foxp3
+
 53,291 911 1,073 
   Spleen CD45Rb
hi
CD44
lo
Fo
xp3
-
 
135,721 31,439 41,642 
   Spleen CD45Rb
lo
CD44
hi
Fo
xp3
-
 
396,380 10,393 12,541 
   Spleen Foxp3+ 133,339 10,502 12,490 
12 18 3 CNS Foxp3
-
 109,483 1,410 1,726 
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Table 3-2. (Continued). 
 
Mouse EAE 
day 
Disease 
score 
Organ Cell type Total 
sequences 
acquired 
Unique 
CDR3 aa 
sequences 
acquired 
Unique 
CDR3 nt 
sequences 
acquired 
   CNS Foxp3
+
 88,279 1,508 1,857 
   Spleen CD45Rb
hi
CD44
lo
Fo
xp3
-
 
133,687 35,012 47,045 
   Spleen CD45Rb
lo
CD44
hi
Fo
xp3
-
 
192,803 12,083 14,474 
   Spleen Foxp3
+
 317,907 14,737 18,525 
13 18 4 CNS Foxp3
-
 288,981 1,429 1,915 
   CNS Foxp3
+
 42,867 1,172 1,362 
   Spleen CD45Rb
hi
CD44
lo
Fo
xp3
-
 
335,855 65,789 95,606 
   Spleen CD45Rb
lo
CD44
hi
Fo
xp3
-
 
225,451 11,932 14,176 
   Spleen Foxp3
+
 290,023 14,003 17,136 
14 18 4 CNS Foxp3
-
 224,925 3,240 4,061 
   CNS Foxp3
+
 385,327 4,077 5,305 
   Spleen CD45Rb
hi
CD44
lo
Fo
xp3
-
 
304,862 46,495 64,598 
   Spleen CD45Rb
lo
CD44
hi
Fo
xp3
-
 
351,771 16,385 20,123 
   Spleen Foxp3
+
 464,759 19,879 25,604 
Cells were flow sorted for CD4, TCR, and, as indicated, GFP-Foxp3, CD45Rb, and 
CD44. 
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Table 3-3. Description of TRBV13-2
+
 TCR sequences acquired from mice with 
late EAE. 
 
Mouse EAE 
day 
Disease 
score 
Organ Cell type Total 
sequences 
acquired 
Unique 
CDR3 aa 
sequences 
acquired 
Unique 
CDR3 nt 
sequences 
acquired 
5 26 1 CNS Foxp3
-
 12,038 1,322 1,399 
   CNS Foxp3
+
 25,388 3,097 3,362 
   Spleen Foxp3
-
 291,902 61,300 90,429 
   Spleen Foxp3
+
 299,258 13,610 16,711 
6 26 2 CNS Foxp3
-
 40,212 3,629 4,039 
   CNS Foxp3
+
 130,450 9,942 11,581 
   Spleen Foxp3
-
 2,735,563 140,052 220,739 
   Spleen Foxp3
+
 123,832 15,375 18,333 
7 26 3 CNS Foxp3
-
 48,451 3,455 3,776 
   CNS Foxp3
+
 1,439 809 828 
   Spleen Foxp3
-
 1,247,903 88,487 132,053 
   Spleen Foxp3
+
 177,834 11,042 12,892 
Cells were flow sorted for CD4, TCR and the presence or absence of GFP-Foxp3. 
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Figure 3-1. TCR TRBJ use during EAE. 
TRBV13-2
+
 TCR repertoires were determined in the spleens of pre-immune mice (n=4) 
and spleens and CNS of mice with early (d 15-18, n=9) or late (d 26, n=3) EAE. TRBJ 
use was tabulated for acquired sequences as an indicator of repertoire diversity. Mean+1 
s.d. percent of unique (a, b) or total (c, d) TRBJ use by CD4
+
GFP-Foxp3
-
 (a, c) and 
CD4
+
GFP-Foxp3
+
 (b, d) derived TCR from individual mice is plotted. 
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Figure 3-2. Association of CNS TCR with the memory T cell pool. 
CNS TCR sequences from sorted CD45RbhiCD44lo or CD45RbloCD44hi T cells from 
the spleens of the same mice (n=5) were compared to determine the association of CNS-
infiltrating sequences with the naïve and memory populations. (a) Percent of unique CNS 
sequences that were identified exclusively in the splenic memory or naïve populations, or 
in both memory and naïve populations are plotted. (b) Percent of total CNS sequences 
acquired were mapped as in (a). 
 27 
 
 
Figure 3-3. Representation of shared TRBV13-2
+
 TCR among CNS-infiltrating 
T cells. 
CNS TRBV13-2
+
 Tconv and Treg TCR repertoires from mice with early (d 15-18, n=9; 
a-c, g-i) or late (d 26, n=3, d-f, j-l) EAE were determined by high-throughput sequencing. 
(a, d, g, j) The proportion of unique TCR amino acid sequences and total TCR 
sequences acquired that were cumulatively identified in the indicated number of mice is 
plotted. (b, e, h, k) The number of unique amino acid sequences shared in the CNS of the 
indicated number of mice with early or late EAE is plotted. (c, f, i, l) The frequency of 
identification of each unique amino acid sequence relative to that of an average sequence 
in the same CNS, was calculated. The mean of this, or representation ratio, for sequences 
shared by the indicated number of mice with early or late EAE is plotted. 
 
 28 
Preferential deployment of public versus private TCR to the autoimmune 
repertoire 
 
The prevalence of the shared TCR in the CNS repertoire did not indicate that 
shared sequences were preferentially employed. Public sequences uninvolved in the 
autoimmune response may have been present at similarly high frequencies, leading to 
their proportionately high utilization
131
. There, TCR from cells involved and uninvolved 
in the CNS response could be directly compared. We proposed one model that if TCR 
engaged in the CNS response were randomly deployed from the public and private 
peripheral repertoires, then splenic sequences identified and not identified in the CNS 
would be expected to be similarly public (Figure 3-4 Model 1). We also proposed an 
alternative model that if public TCR were preferentially incorporated into the CNS 
response, the splenic sequences also seen in the CNS should be enriched in public 
sequences (Figure 3-4 Model 2).To assess this and establish the extent to which CNS-
infiltrating T cells are public, we analyzed the more abundant TCR sequences in the 
spleen.  
EAE splenic TCRmapped onto CNS TCRrepertoires 
 
To test our hypothesized models, we were able to map the splenic 
TCRsequences from the mice with EAE onto CNS TCRrepertoires. Splenic TCR 
sequences also seen in the CNS were markedly more likely to be shared than sequences 
not observed in the CNS. For example, 28.5% of the unique CNS Foxp3
-
 sequences from 
mice with early disease were identified in all spleens analyzed compared with 2.7% of 
non-CNS sequences, indicating that many CNS sequences are derived from the public 
repertoire (Figure 3-5a). Pairwise analysis of the sharing of CNS and non-CNS 
sequences between individual mice verified this finding (Figure 3-5c). Results were 
similar in mice with late disease (Figure 3-5b, c) and for Foxp3
+
 T cells (Figure 3-5d-f). 
 
When we analyzed the total splenic TCR sequences, the results above 
enumerating unique TCR sequences acquired was replicated tabulating, and this also 
showed a dramatically enhanced sharing of CNS compared with non-CNS sequences 
(Figure 3-6). 
Over-representation of CNS T cell-associated TCR in the pre-immune 
public repertoire 
 
Our previous analysis of the preferential recruitment and expansion of public 
splenic T cells was derived from the context of CNS inflammation. To circumvent the 
distortion from immune responses, we proposed that CNS infiltrating TCR should be 
disproportionately public in pre-immune mice too. To test this, we mapped splenic TCR 
sequences from mice with EAE onto pre-immune repertoires. For all samples analyzed, 
either Foxp3
-
 or Foxp3
+
 and early or late disease, substantially more CNS-infiltrating 
than non-infiltrating TCR sequences were identified as public in the pre-immune 
repertoire (Figure 3-7). This again was true both for unique and total TCR sequences 
analyzed. Together, these data support a heavily biased public TCR usage in the EAE  
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Figure 3-4. Models for the high frequency of shared CNS TCR. 
In model 1, the high frequency of shared CNS TCR is explained by a generally high 
frequency of public relative to private TCR. In this model, T cells are randomly 
recruited to and expand within the autoimmune repertoire. Splenic TCR that are present 
within the CNS repertoire will show similar proportions of public sequences as TCR 
that are uninvolved in the autoimmune process. In model 2, public TCR are 
disproportionately recruited to and/or expand within the autoimmune response. In this 
case, there is a greater representation of public TCR among splenic sequences identified 
within the CNS than those unassociated with CNS autoimmunity.  
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Figure 3-5. Over-representation of unique public sequences in the CNS-
infiltrating repertoire. 
Splenic CD4
+ 
GFP-Foxp3
-
 and GFP-Foxp3
+
 TRBV13-2
+
 TCR repertoires from mice 
with early (d 15-18; n=4) or late (d 26; n=3) EAE were segregated into sequences 
identified or not within the CNS. Percent of unique TCR sequences that were shared by 
the indicated number of mice with early (a, d) and late (b, e) disease is shown. (c, f) The 
overlap of the repertoire from each mouse was compared pairwise with that of every 
other mouse in a cohort. 
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Figure 3-6. Over-representation of total public sequences in the CNS-infiltrating 
repertoire. 
Analyses were performed on the same data sets as in Figure 3-5, however overlap among 
total, rather than unique, TCR sequences acquired was assessed. For this, frequencies 
were normalized so total sequence number was effectively equal in each mouse. This 
ensured that the weighting of each mouse in calculations was equivalent. Percent of total 
TCR sequences that were shared by the indicated number of mice with early (a, d) and 
late (b, e) disease is shown. (c, f) The overlap of the repertoire from each mouse was 
compared pairwise with that of every other in a cohort. 
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Figure 3-7. Over-representation of unique and total CNS-associated Foxp3
+
 and 
Foxp3
-
 public TCR in the pre-immune repertoire. 
Splenic TRBV13-2
+
 TCR amino acid repertoires from CD4+GFP-Foxp3- and GFP-
Foxp3
+
 T cells of mice with early (d 15-18; n=4) or late (d 26, n=3) EAE were mapped 
onto the splenic CD4
+
GFP-Foxp3
-
 or CD4
+
GFP-Foxp3
+
 repertoires from pre-immune 
mice (CTRL; n=4). Percent of unique CD4
+
GFP-Foxp3
-
 sequences that were or were not 
identified in the CNS from mice with early (a) or late (b) EAE and also present in the 
CD4
+
GFP-Foxp3
-
 repertoires of the indicated number of pre-immune spleens is plotted. 
(c) As in (a, b), but the overlap of repertoires from individual mice with EAE and 
individual pre-immune mice is plotted. (d-f) Analyses are equivalent to (a-c), but 
assessing unique sequence overlap between CD4
+
GFP-Foxp3
+
 repertoires. (g-l) Parallel 
analyses of total CD4
+
GFP-Foxp3
-
 and CD4
+
GFP-Foxp3
+
 sequences acquired from mice 
with early or late EAE and pre-immune mice. As in Figure 3-5, sequence events were 
normalized for comparisons of total sequence overlap between mice, effectively 
equalizing the total number of sequences in each mouse. 
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repertoire, with this preference traceable to the pre-immune repertoire.  
Temporal focusing of the public TCR repertoire 
 
To determine whether the extent of sharing of autoimmune repertoires differed in 
early and late EAE, we next compared CNS repertoires from individual mice. Overlap of 
CNS sequences was lowest when pairs of d 15-18 mice were compared with each other. 
Repertoire overlap increased when d 15-18 mice were compared with d 26 mice, and was 
greatest when d 26 mice were compared (Figure 3-8a, b). Splenic TCR overlap, unlike 
that of CNS TCR, did not change with disease stage (Figure 3-8c, d). Therefore the 
extent of sharing increases specifically with time in the disease-associated repertoire. 
That mice with early disease shared more of their CNS repertoire with late disease mice 
than with each other further indicates a temporal focusing of the shared CNS repertoire. 
Recombinatorial bias and oligoclonality in autoimmune repertoire formation 
 
Considering the relatedness of the d 15-18 and d 26 repertoires, we combined the 
12 CNS data sets we acquired to identify common TCR sequences. Forty eight TCR 
were identified in ≥10 of the 12 CNS repertoires (Table 3-4). These receptors were 
oligoclonal with multiple nt sequences used for each CNS amino acid sequence 
cumulatively (range 2-59, median=13) and within single mice (mean 2.8±1.3). Consistent 
with their oligoclonal presence, in individual CNS 46.7±19.9% of the 48 public TCR 
were identified in both the Foxp3
+
 and Foxp3
-
 lineages compared with 2.9±1.9% of 
private sequences (p<10
-5
). 
Biased rearrangement of public TCR in the thymus of pre-immune mice 
 
Given that the prevalence of CNS public sequences can be traced into splenic 
repertoire of pre-immune mice. We questioned whether these public TCR originated 
from the thymus with high probability of forming. Indeed, public TCR have been 
proposed for a high probability of forming in the thymus due to a process called biased 
recombination
44,132,133
. To assess this in the autoimmune public repertoire, we analyzed 
pre-selection CD4
+
CD8
+
TCR
lo
 (DP) repertoires in pre-immune mice
131
. Nucleotide 
sequence diversity of each of the 48 public TCR was compared with that of paired 
private TCR from the same mouse with identical V, J and CDR3 length, and similar 
identification frequencies (>0.25 – <4 fold). The public sequences displayed markedly 
greater pre-selection nt variability than control private sequences (6.2±2.9 vs 1.1±0.1 nt 
sequences) (Figure 3-9), indicating that these have an increased probability of forming 
and the pre-selection recombinatorial biases foster disease-associated public repertoire 
formation. 
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Figure 3-8. Repertoire focusing in mice with EAE. 
CNS TCR repertoires of CD4+GFP-Foxp3- and Foxp3+ T cells were compared between 
individual mice with early and late disease to determine changes in the overlap between 
repertoires with disease progression. Percent CNS CD4
+
GFP-Foxp3
-
 (a) and Foxp3
+
 (b) 
CNS TCR repertoire overlap between individual mice with early disease, mice with 
early versus late disease, and mice with late disease is plotted. Comparable analyses were 
performed on splenic CD4
+
GFP-Foxp3
-
 (c) and CD4
+
GFP-Foxp3
+
 (d) TCRrepertoires. 
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Table 3-4. Highly shared CNS CDR3 sequences. 
 
    Foxp3
-
  Foxp3
+
 
CDR3 sequence CNS 
shared 
CNS 
shared 
(Foxp3
-
) 
CNS 
shared 
(Foxp3
+
) 
Mean 
(%) 
Median 
(%) 
Range 
(%) 
 Mean 
(%) 
Median 
(%) 
Range 
(%) 
ASGETGGNYAEQF    12    12    12 0.986 0.235 (0.017-
5.375) 
 1.818 1.774 (0.008-
4.346) 
ASGQDTQY    12    10    11 0.086 0.014 (<0.001-
0.591) 
 0.150 0.018 (0.002-
0.978) 
ASGDRYEQY    12    12     8 0.248 0.221 (0.008-
0.626) 
 0.047 0.009 (0.001-
0.290) 
ASGEYEQY    12     7    11 0.102 0.008 (0.001-
0.605) 
 0.166 0.069 (0.006-
0.940) 
ASGDNYNSPLY    12     8    10 0.015 0.009 (<0.001-
0.060) 
 0.061 0.008 (<0.001-
0.281) 
ASGDAGNTLY    12     7    10 0.093 0.020 (<0.001-
0.351) 
 0.158 0.089 (0.002-
0.772) 
ASGDSYNSPLY    11     9    10 0.182 0.024 (0.005-
1.359) 
 0.061 0.010 (0.001-
0.221) 
ASGEDTQY    11    11     7 0.299 0.015 (<0.001-
3.081) 
 0.029 0.012 (0.002-
0.139) 
ASGYEQY    11     8     9 0.013 0.009 (0.002-
0.044) 
 0.609 0.047 (0.009-
5.187) 
ASGETANSDYT    11     6    10 0.019 0.006 (0.001-
0.087) 
 0.872 0.592 (0.001-
3.136) 
ASGDSSGNTLY    11     7     9 0.006 0.006 (<0.001-
0.017) 
 0.140 0.019 (<0.001-
0.503) 
ASGEAGGNYAEQF    11     7     9 0.003 0.002 (<0.001-
0.009) 
 0.086 0.009 (0.001-
0.662) 
 
 37 
Table 3-4. (Continued). 
 
    Foxp3
-
  Foxp3
+
 
CDR3 sequence CNS 
shared 
CNS 
shared 
(Foxp3
-
) 
CNS 
shared 
(Foxp3
+
) 
Mean 
(%) 
Median 
(%) 
Range 
(%) 
 Mean 
(%) 
Median 
(%) 
Range 
(%) 
ASGDAGNSDYT    11     7     8 0.534 0.082 (0.002-
3.315) 
 0.065 0.023 (0.001-
0.175) 
ASGDRGYEQY    11     6     8 0.008 0.003 (0.001-
0.033) 
 0.164 0.039 (0.001-
0.583) 
ASGDNSGNTLY    10    10     9 0.084 0.010 (<0.001-
0.577) 
 0.119 0.054 (<0.001-
0.664) 
ASGDAGGSYEQY    10     8    10 0.217 0.059 (0.001-
1.221) 
 0.067 0.040 (0.001-
0.225) 
ASGDDEQY    10    10     8 0.065 0.010 (<0.001-
0.481) 
 0.091 0.010 (<0.001-
0.352) 
ASGDAGYEQY    10     8     9 0.033 0.025 (0.004-
0.103) 
 0.176 0.073 (0.001-
0.860) 
ASGDEQY    10     8     9 0.009 0.003 (0.001-
0.033) 
 0.189 0.045 (0.010-
1.091) 
ASGDQDTQY    10     9     8 0.014 0.006 (<0.001-
0.042) 
 0.050 0.013 (0.002-
0.267) 
ASGDAETLY    10     6    10 0.016 0.006 (0.001-
0.059) 
 0.104 0.019 (<0.001-
0.619) 
ASGGTGGNYAEQF    10     6    10 0.003 0.001 (<0.001-
0.013) 
 0.099 0.048 (0.002-
0.343) 
ASGDAGGYEQY    10     8     8 0.013 0.015 (<0.001-
0.030) 
 0.069 0.068 (<0.001-
0.219) 
ASGDWGSAETLY    10     8     8 0.016 0.006 (0.001-
0.050) 
 0.031 0.006 (<0.001-
0.169) 
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Table 3-4. (Continued). 
 
    Foxp3
-
  Foxp3
+
 
CDR3 sequence CNS 
shared 
CNS 
shared 
(Foxp3
-
) 
CNS 
shared 
(Foxp3
+
) 
Mean 
(%) 
Median 
(%) 
Range 
(%) 
 Mean 
(%) 
Median 
(%) 
Range 
(%) 
ASGPYEQY    10     7     8 0.143 0.008 (0.001-
0.913) 
 0.277 0.043 (0.001-
1.681) 
ASGDSAETLY    10     8     7 0.007 0.008 (0.001-
0.017) 
 0.146 0.032 (<0.001-
0.659) 
ASGDSYEQY    10     8     7 0.037 0.013 (0.001-
0.123) 
 0.018 0.012 (0.001-
0.069) 
ASGGTGGYEQY    10     9     6 0.035 0.008 (0.001-
0.204) 
 0.020 0.011 (0.002-
0.069) 
ASGDRGNTEVF    10     7     8 0.031 0.002 (0.001-
0.134) 
 0.011 0.002 (<0.001-
0.070) 
ASGDRGSGNTLY    10     9     6 0.027 0.005 (0.001-
0.130) 
 0.014 0.003 (<0.001-
0.069) 
ASGDADTQY    10     7     7 0.042 0.030 (<0.001-
0.149) 
 0.017 0.001 (0.001-
0.059) 
ASGGGQNYAEQF    10     9     5 0.054 0.038 (0.002-
0.143) 
 0.005 0.003 (0.002-
0.012) 
ASGDAGSQNTLY    10     6     8 0.013 0.012 (0.002-
0.024) 
 0.045 0.017 (0.001-
0.179) 
ASGDAGEQY    10     8     6 0.019 0.008 (<0.001-
0.091) 
 0.028 0.008 (0.001-
0.112) 
ASGDAGGQNTLY    10     7     7 0.006 0.004 (<0.001-
0.017) 
 0.030 0.027 (0.002-
0.073) 
ASGDGYEQY    10     7     7 0.004 0.003 (0.001-
0.008) 
 0.031 0.006 (0.001-
0.143) 
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Table 3-4. (Continued). 
 
    Foxp3
-
  Foxp3
+
 
CDR3 sequence CNS 
shared 
CNS 
shared 
(Foxp3
-
) 
CNS 
shared 
(Foxp3
+
) 
Mean 
(%) 
Median 
(%) 
Range 
(%) 
 Mean 
(%) 
Median 
(%) 
Range 
(%) 
ASGDPGGYEQY    10     6     8 0.014 0.005 (0.001-
0.062) 
 0.016 0.009 (0.001-
0.069) 
ASGDAGGQDTQY    10     8     6 0.005 0.004 (<0.001-
0.015) 
 0.020 0.011 (0.001-
0.078) 
ASGDVEQY    10     5     8 0.020 0.006 (<0.001-
0.079) 
 0.105 0.026 (<0.001-
0.386) 
ASGDEDTQY    10     8     5 0.011 0.007 (0.001-
0.033) 
 0.084 0.005 (0.001-
0.325) 
ASGDAWGGYEQY    10     5     8 0.049 0.041 (0.002-
0.125) 
 0.040 0.009 (0.001-
0.210) 
ASGEGTGGYEQY    10     8     5 0.060 0.009 (<0.001-
0.311) 
 0.002 0.001 (<0.001-
0.008) 
ASGDNYEQY    10     8     5 0.005 0.003 (0.001-
0.017) 
 0.016 0.006 (0.002-
0.048) 
ASGDAGTGGYEQY    10     8     5 0.013 0.005 (0.001-
0.052) 
 0.005 0.003 (0.001-
0.015) 
ASGEQGYEQY    10     5     7 0.180 0.002 (0.001-
0.700) 
 0.028 0.008 (0.001-
0.140) 
ASGDGGNQDTQY    10     8     4 0.045 0.028 (0.008-
0.167) 
 0.004 0.005 (0.001-
0.008) 
ASGDWGSSYEQY    10     5     6 0.089 0.008 (0.001-
0.376) 
 0.039 0.016 (<0.001-
0.168) 
ASGGQNTEVF    10     6     5 0.002 0.002 (<0.001-
0.005) 
 0.018 0.004 (0.001-
0.043) 
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Table 3-4. (Continued). 
 
Sequences for 48 TRBV13-2
+
 CDR3 from TCR identified as highly shared in the CNS are listed. The number of mice in which the 
sequences were identified (n=12 total) in Foxp3
-
 and Foxp3
+
 T cells is listed, as is the mean, median, and range of the percent of total 
CNS sequences acquired with the indicated amino acid sequence. 
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Figure 3-9. Formation of the public autoimmune TCR repertoire through biased 
recombination. 
To determine the diversity of the public autoimmune repertoire in pre-selection 
thymocytes, nucleotide (nt) sequences identified for 48 highly public CNS TCR amino 
acid sequences were assessed in sorted pre-selection CD4
+
CD8
+
TCR
lo
 thymocytes from 
healthy mice (n=4). The mean number of unique nt sequences per thymus for each of the 
48 sequences is plotted. For each CNS sequence, paired control private sequences were 
identified in each mouse with the same TRBV, TRBJ, and CDR3 length, and similar 
frequency (>0.25-<4 fold) as the public sequence for comparison. Mean unique nt 
sequences is similarly plotted. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 42 
Functional Characterization of the CNS Public TCRin Retrogenic Mice Model 
Spontaneous autoimmunity mediated by a public TCR
 
Autoantigen-specific T cells are readily identifiable in the T cell repertoire of 
healthy individuals
133-135
. The preferential use of public TCR during EAE suggested a 
role for direct evidence. To better define the impact of public TCR, we generated 
retroviral transgenic (retrogenic) mice that enforced the expression of the most common 
public TCRsequence, TCR1 (Table 3-5)101,123,136. 
Phenotypic characterization of TCR1 retrogenic mice 
 
Impressively, TCR1 retrogenic mice developed spontaneous EAE with very 
early T cell engraftment at ~4 wk (Figure 3-10a). Indeed, numbers of T cells infiltrating 
the CNS at this time were similar to numbers in the spleen (Figure 3-10b). CD4
+
Foxp3
-
, 
CD4
+
Foxp3
+
, and CD8
+
 T cells engrafted (Figure B-2, B-3), and the CD69 activation 
marker was expressed on 31±5% and 81±5% of splenic and CNS T cells from diseased 
mice respectively (Figure 3-10a-d, Figure B-2). Mortality was >50% (Figure 3-10a). 
TCR1+ T cells proliferated strongly to MOG35-55 and CNS and splenic cells 
demonstrated Th1 and Th17 subset differentiation and a histologic pattern consistent with 
optico-spinal encephalomyelitis (Figure 3-10c-f, Figure 3-11e-g). Notably, disease in 
mice retrogenic for just the TCR1 monomer was markedly accelerated, increased in 
incidence, and more severe than our prior results with retrogenic mice expressing five 
different disease-associated private MOG-specific TCR heterodimers101. 
TCR1 imposes MOG35-55 specificity on TCR heterodimers 
 
TCR1 retrogenic mice were enforced to express a single TCRchain (TCR 
pairing with endogenous random TCRchainshe corresponding TCR repertoire would 
be limited but diverse enough for a wide spectrum of TCR specificity. Referred to our 
observation, we hypothesized that single TCR1might dominate MOG35-55 recognition on 
TCR with diverse TCR. To establish pairing requirements, we co-expressed TCR1 
with 7 TCR chains isolated from non-TCR1 TCR. We reconstituted the TCR 
heterodimers and enforced the expression on CD4 4G4 hybridoma cell lines. In vitro, 
MOG35-55 stimulation assay showed two of the hybrid TCR responded to MOG35-55, 
indicating that TCR1 can drive MOG responsiveness with random TCR chain (Figure 
3-12). TCR cDNA was further isolated from CNS-infiltrating T cells from 3 TCR1 
mice by 5’ RACE and subcloned. These were heterogeneous and did not overlap between 
mice (Table 3-6), indicating that TCR1 is associated with many TCR. 
Protective role of the co-engrafted wide type (WT) cells in chimeric 
retrogenic mice 
 
To determine whether non-transgenic T cells impede spontaneous EAE mediated 
by TCR1, we generated chimeric retrogenic mice, mixing wild type CD45.1+CD45.2- 
and smaller numbers of congenic TCR1-transduced CD45.1-CD45.2+ hematopoietic 
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Table 3-5. TCR retrogenic mice. 
 
TCR name TRBJ CDR3 sequence CNS 
shared 
(Total, 
n=12) 
CNS 
shared 
(Foxp3
-
) 
CNS 
shared 
(Foxp3
+
) 
SPL 
Shared 
(Total, 
n=9) 
SPL 
shared 
(Foxp3
-
) 
SPL 
shared 
(Foxp3
+
) 
CNS shared, Public (group 1) 
TCR1   2-1 ASGETGGNYAEQF    12    12    12     9     9     9 
TCR2   2-7 ASGDRYEQY    12    12     8     9     9     9 
TCR3   2-7 ASGYEQY    11     8     9     9     9     9 
TCR4   1-2 ASGETANSDYT    11     6    10     9     9     9 
TCR5   2-7 ASGDAGGSYEQY    10     8    10     9     9     9 
TCR6   2-7 ASGDGEQY     9     4     9     9     9     9 
CNS non-shared, Public (group 2) 
TCR7   2-1 ASGEQQGTEQF     1     1     1     3     3     1 
TCR8   2-7 ASGDGLGGSYEQY     1     1     0     9     9     5 
TCR9   1-6 ASGDVRGYNSPLY     1     0     1     2     1     1 
TCR10   1-2 ASGDGTSNSDYT     1     0     1     9     9     2 
Private (group 3) 
TCR11   2-5 ASGIGDTQY     1     0     1     1     1     1 
TCR12   2-7 ASGDAGTGYEQYF       
TCR13   2-4 ASGDWGGEDTLYF       
TCR14   2-4 ASGDETGGAYEQYF       
TCR15   2-3 ASGGGLGGTSAETLYF       
Control 
OT-II   2-4 ASSLGGESQNTLYF       
 
 
 
 
 44 
Table 3-5. (Continued). 
 
TRBV13-2
+
 TCR  chains that were shared in total, Foxp3-, and Foxp3+ populations in the CNS and spleen of the indicated number of 
mice were transduced into TCR-/- HPC and retrogenic mice generated. For TCR chains identified in a single mouse, the percent of 
total TRBV13-2
+
 TCR sequences in the CNS bearing the indicated sequence is listed in parentheses. For shared CNS sequences, 
frequency means, medians, and ranges are provided in Table 3-1. Sequences 12-15 were isolated from primary TRBV13-2+ MOG35-
55-specific T cell hybridomas in our laboratory, and were not observed in any of the mice evaluated for the repertoire analyses here. 
OT-II comprises the TCR chain from the ovalbumin 323-229-specific OT-II TCR, and was assessed as a negative control. 
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Figure 3-10. Enforced public TCR expression leads to spontaneous autoimmune 
encephalomyelitis. 
Retrogenic mice were generated by transducing TCR-/-, GFP-Foxp3 HPCs with TCR1. 
(a) Kaplan Meier analysis of survival and disease-free survival. (b) Absolute numbers of 
CD4
+
TCR
+
 and CD4
+
TCR
+
GFP-Foxp3
+
 T cells in spleens and CNS of TCR1 mice with 
EAE. (c) Proliferation of splenic T cells from TCR1 or control retrogenic mice 
expressing an OT-II TCR (ovalbumin-specific)-derived  chain in response to MOG35-55 
or mitogen measured by 
3
H-thymidine incorporation. (d) Percent of CNS-infiltrating T 
cells expressing IL-17, IFN-, or both IL-17 and IFN- in the absence or presence of ex-
vivo restimulation, as determined by intracellular cytokine staining, is plotted. (e, f) 
Histologic analyses of the CNS of TCR1 retrogenic mice showing a mixed infiltrate of 
lymphocytes, macrophages, and granulocytes, gliosis and perivascular cuffing in the 
septum, meninges, and optic nerve (e) and white tracts of the lumbar spinal cord (f) in 
day 28 TCR1 mice but not control retrogenic mice.  
 
 46 
 
 
Figure 3-11. Characterization of spontaneous EAE development in TCR1 
retrogenic mice. 
Percent of CD4
+
TCR
+
 and CD8
+
TCR
+
 T cells within the lymphocyte gate in day 30-35 
TCR1 mice in the spleen (a) and CNS (b). ****, p<0.0001. (c) The percent of 
CD4
+
TCR
+
 lymphocytes expressing GFP-Foxp3 in the spleens and CNS of TCR1 and 
control OT-II TCR retrogenic mice is plotted. Groups are NS by ANOVA. (d) The 
percent of activated CD4+TCR
+
 T cells was determined by CD69 activation marker 
expression in the spleen and CNS and compared with results in the spleens of OT-II 
TCR mice. (e) Splenic and CNS T cells from TCR1 mice with EAE were stimulated ex 
vivo with mitogen and IFN- and IL-17 production measured by intracellular staining. 
Representative data is shown. Summary data is provided in figure 6d. (f) Splenocytes 
from TCR1 mice with EAE were stimulated with myelin MOG35-55 and secretion of the 
indicated cytokines measured by bead array. (g) Major organs from TCR1 mice with 
EAE were analyzed histologically. Inflammation was localized to the CNS. Scoring of 
the indicated CNS regions was performed by a blinded reviewer as described under 
Methodology.  
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Figure 3-12. TCR1+ TCR recognize MOG35-55. 
To determine the pairing requirements of the TCR1 chain for MOG35-55 recognition, we 
linked to it 7 TCR chains derived from alternative (non-TCR1) TCR in polycistronic 
retroviral constructs. TCR chains and TCR1 were separated by the T. asigna 2A 
sequence to support stoichiometric production of each chain, and cloned into the IRES-
GFP retroviral vector. Retrovirus was transduced into 4G4 TCR-deficient cells that we 
had transfected to express CD4. TCR+ cells were flow cytometrically sorted, and 
stimulated with MOG35-55 or anti-CD3. IL-2 production was measured by ELISA at 24 
hr. (a) TCR chains that when paired with TCR1 conferred MOG35-55 responsiveness. 
(b) TCR chains that did not confer MOG35-55 responsiveness. 
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Table 3-6. Distinct TCR chains isolated from CNS CD4+GFP-Foxp3+ and GFP-
Foxp3
-
 T cells from TCR1 mice with EAE. 
 
Mouse Source Cell 
type 
TRAV TRAJ CDR3 
5’RACE clones:      
1 CNS Foxp3
-
 TRAV13-2 TRAJ26 CAPPAHAQGLTF 
1 CNS Foxp3
-
 TRAV13D-1 TRAJ37 CALITGNTGKLIF 
1 CNS Foxp3
-
 TRAV14-2 TRAJ26 CAARTYAQGLTF 
1 CNS Foxp3
-
 TRAV14D-3 TRAJ31 CAARKNSNNRIFF 
1 CNS Foxp3
-
 TRAV4D-3 TRAJ49 CAAVTGYQNFYF 
1 CNS Foxp3
-
 TRAV4D-4 TRAJ42 CAASGGSNAKLTF 
1 CNS Foxp3
-
 TRAV4D-4 TRAJ57 CAAGQGGSAKLIF 
1 CNS Foxp3
-
 TRAV4N-3 TRAJ27 CAAGGYTGKLTF 
1 CNS Foxp3
-
 TRAV6D-6 TRAJ57 CALGDRGSAKLIF 
1 CNS Foxp3
-
 TRAV7-1 TRAJ21 CAVRKRSNYNVLYF 
1 CNS Foxp3
-
 TRAV7-2 TRAJ23 CAASMDYNQGKLIF 
1 CNS Foxp3
-
 TRAV7-3 TRAJ34 CAVSPQSSNTNKVVF 
1 CNS Foxp3
-
 TRAV7-4 TRAJ12 CAASGRTGGYKVVF 
1 CNS Foxp3
-
 TRAV7-4 TRAJ21 CAASARSNYNVLYF 
1 CNS Foxp3
-
 TRAV7-6 TRAJ33 CAASNYQLIW 
1 CNS Foxp3
-
 TRAV8-1 TRAJ39 CATPYNNAGAKLTF 
1 CNS Foxp3
-
 TRAV9N-2 TRAJ35 CVLSSGFASALTF 
1 CNS Foxp3
-
 TRAV9N-2 TRAJ35 CVLSAGFASALTF 
1 CNS Foxp3
-
 TRAV9N-3 TRAJ39 CAVSAINAGAKLTF 
2 CNS Foxp3
-
 TRAV12-2 TRAJ33 CALSARVNYQLIW 
2 CNS Foxp3
-
 TRAV14D-1 TRAJ57 CAASPQNQGGSAKLIF 
2 CNS Foxp3
-
 TRAV6-2 TRAJ17 CVLGDRRSAGNKLTF 
2 CNS Foxp3
-
 TRAV6-3 TRAJ45 CAMSGADRLTF 
2 CNS Foxp3
-
 TRAV7-4 TRAJ9 CAAGISNMGYKLTF 
2 CNS Foxp3
-
 TRAV7-4 TRAJ9 CAARISNMGYKLTF 
3 CNS Foxp3
-
 TRAV19 TRAJ24 CAVPASLGKLQF 
3 CNS Foxp3
-
 TRAV4D-3 TRAJ21 CAAGGYNVLYF 
3 CNS Foxp3
-
 TRAV7-3 TRAJ27 CAANTGKLTF 
3 CNS Foxp3
-
 TRAV7D-3 TRAJ37 CAVGGNTGKLIF 
1 CNS Foxp3
+
 TRAV13D-1 TRAJ39 CALVMNNNAGAKLTF 
1 CNS Foxp3
+
 TRAV4D-3 TRAJ50 CAARSSSSFSKLVF 
1 CNS Foxp3
+
 TRAV4D-3 TRAJ42 CAAGGSNAKLTF 
1 CNS Foxp3
+
 TRAV4D-4 TRAJ57 CAAALNQGGSAKLIF 
1 CNS Foxp3
+
 TRAV4D-4 TRAJ57 CAAGQGGSAKLIF 
1 CNS Foxp3
+
 TRAV4N-3 TRAJ47 CAAVPMDYANKMIF 
1 CNS Foxp3
+
 TRAV7-2 TRAJ9 CAASWMGYKLTF 
1 CNS Foxp3
+
 TRAV7-3 TRAJ22 CAVSASSGSWQLIF 
1 CNS Foxp3
+
 TRAV7-3 TRAJ22 CAVSMSFGSWQLIF 
1 CNS Foxp3
+
 TRAV7-4 TRAJ12 CAASGRTGGYKVVF 
1 CNS Foxp3
+
 TRAV7D-3 TRAJ22 CAVSISGSWQLIF 
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Table 3-6. (Continued). 
 
Mouse Source Cell 
type 
TRAV TRAJ CDR3 
2 CNS Foxp3
+
 TRAV12-3 TRAJ39 CALRRGNAGAKLTF 
2 CNS Foxp3
+
 TRAV7-6 TRAJ32 CAVLGSSGNKLIF 
2 CNS Foxp3
+
 TRAV9D-3 TRAJ32 CALSPYGSSGNKLIF 
2 CNS Foxp3
+
 TRAV9D-3 TRAJ32 CALSPYESSGNKLIF 
3 CNS Foxp3
+
 TRAV21 TRAJ49 CILKTGYQNFYF 
3 CNS Foxp3
+
 TRAV6-5 TRAJ49 CILKTGYQNFYF 
Additional TRAV4 amplification clones:   
3 CNS Foxp3
+
 TRAV4D-3 TRAJ33 CAAPDSNYQLIW 
3 CNS Foxp3
+
 TRAV4D-3 TRAJ57 CAARQGGSAELIF 
3 CNS Foxp3
+
 TRAV4D-3 TRAJ40 CAAPGNYKYVF 
3 CNS Foxp3
+
 TRAV4D-3 TRAJ39 CAAGGDNAGAKLTF 
3 CNS Foxp3
+
 TRAV4D-3 TRAJ50 CAAIASSSFSKLVF 
3 CNS Foxp3
+
 TRAV4D-4 TRAJ57 CAAENQGGSAKLIF 
TCR were isolated by 5’RACE except for a subset of Foxp3+ clones from mouse 3 that 
were isolated with TRAV4 and TCR C-specific primers. 
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progenitor cells (HPCs). Approximately 40% of mice were protected from disease 
(Figure 3-13a). TCR1+ cells were a minority, though less frequent in mice protected 
from than developing EAE (Figure 3-13c). When EAE developed, symptoms were 
milder and mortality diminished, consistent with a protective role for the co-engrafted 
WT cells. We anticipated that TCR1 imposes MOG-recognition on T cells, and that this 
should occur even in healthy animals. To test this, we analyzed disease-free chimeric 
mice. TCR1+CD45.2+ but not WT CD45.1+ T cells from unprimed disease-free mice 
proliferated strongly to MOG35-55 (Figure 3-13b, d-e). An estimated 15.6±7.8% of the 
initial population of CD45.2
+
 T cells responded to MOG35-55 compared to 49.2±12.3% to 
control CD3/CD28. 
Public but not private TCR confer myelin specificity and provoke 
spontaneous autoimmunity 
 
TCR1 is to our knowledge the first example of a single TCR chain endowing a 
heterogeneous population of T cells with overt spontaneous autoreactivity. To more 
comprehensively define the impact of public TCR in autoimmune susceptibility, we 
generated 14 additional TCR retrogenic mice using five additional TCR identified in 
≥9 CNS and all spleens (group 1), four in a single CNS at high frequency and shared in 
splenocytes to varying extents (group 2), and five that were wholly private (group 3; 
Table 3-5). A majority of CNS-infiltrating T cells in MOG-EAE recognize the MOG35-55 
epitope
137
. To minimize the possibility that TCR selected for analysis were derived from 
non-specific bystander T cells, group 2 and 3 TCR were either derived from high 
frequency CNS-infiltrating clones or private TCR sequences demonstrated to 
recognize MOG35-55 autoantigen. For each TCR, mice were monitored for ≥120 days or 
until the development of clinical disease, at which time all major organs were assessed 
grossly and histologically. T cells from disease-free mice were assayed for MOG35-55-
specific responsiveness. 
 
Of the additional group 1 TCR, none developed spontaneous EAE, though 2 of 
the 5 mice showed autoimmune features. Unprimed T cells from TCR4 mice 
proliferated strongly in response to MOG35-55 as measured both by 
3
H-thymidine 
incorporation and membrane-associated dye dilution assays (Figure 3-14a-c). Therefore, 
like TCR1, this TCR endows a large proportion of disparate TCR with specificity 
for the MOG35-55 autoantigen. Meanwhile, T cells from TCR7 (group 2) proliferated 
weakly to MOG35-55. This was detectable by 
3
H-thymidine incorporation but not the less 
sensitive dye dilution assay (Figure 3-14d). However, mice expressing the 5 private 
group 3 TCR did not show any evidence for myelin reactivity. 
 
Notably, TCR3 T cells did not respond to MOG35-55. However, with early 
engraftment these mice developed spontaneous alopecia and esophagitis (Figure 3-15). 
This was associated with prominent T cell infiltrates in these locations. TCR3 
implicated that some CNS-associated public TCR may provoke alternative types of 
spontaneous autoimmunity. Except TCR1 and TCR3, there was no other histologic or 
clinical evidence of disease in mice expressing any of the other 4 group 1 CNS public  
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Figure 3-13. Spontaneous EAE was protected by the co-engrafted WT cells in 
chimeric retrogenic mice. 
Chimeric retrogenic mice were generated by transducing wild type (WT) 
CD45.1
+
CD45.2
-
 and congenic TCR1-transduced CD45.1-CD45.2+ hematopoietic. (a) 
Disease-free and overall survival of mice chimeric for WT (CD45.1
+
) and TCR1 
(CD45.2
+
) T cells are plotted. (b) Ex-vivo proliferation of CD4
+
CD45.1
+
 (TCR1-) and 
CD4
+
CD45.2
+
 (TCR1+) T cells from a representative 8 wk disease-free retrogenic 
mouse was measured by CellTrace
TM
 Violet dilution 72 hr after stimulation. (c) 
Peripheral blood samples were collected at day 28 from mice chimeric for TCR1+ and 
TCR
WT
 T cells. The percent of CD4
+
TCR
+
CD45.2
+
 (TCR1+) T cells among total 
CD4
+
TCR
+
 T cells in chimeric mice developing or not developing EAE is plotted. (d) 
CD4
+
TCR
+
CD45.2
+
 (TCR1+) and CD4+TCR+CD45.1+ (TCRWT) T cells were flow 
cytometrically sorted from 8 wk chimeric mice without current or historical signs of 
EAE. The cells were stimulated as indicated and proliferation measured on day 3 by 
3
H-
thymidine incorporation. (e) T cells from 8 wk disease-free chimeric mice were labeled 
with CellTrace
TM
 Violet and stimulated as indicated. At 72 hr, proliferation of 
CD4
+
TCR
+
 CD45.2
+
 and CD45.1
+
 cells was determined as in figure 6h. The magnitude 
of each division peak was divided by 2
x
, where x=division peak number, to estimate 
numbers of parental cells whose progeny populated an individual peak. Based on this, the 
percent of total parental cells that had divided was calculated and is plotted. 
 
 52 
 
 
Figure 3-14. Public TCRTCR impose MOG-reactive TCR repertoires. 
(a) Proliferation of T cells from unprimed and disease-free retrogenic TCR4 mice was 
measured by dye dilution 72 hr after stimulation as indicated. (b) The percent of initial 
cells dividing in response to the indicated stimulus was calculated by dividing each 
division peak by 2
n
, where n=division number, to estimate initial cell numbers forming 
each peak. (c) Proliferative response of purified TCR4 T cells measured using 3H-
thymidine incorporation. Circles indicate means of triplicates from individual mice. (d) T 
cells from TCR7 retrogenic mice were isolated and stimulated as indicated. Proliferative 
response was measured at 72 hr by 
3
H-thymidine incorporation. Circles indicate means of 
triplicates from individual mice. 
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Figure 3-15. Heightened public TCR autoreactivity. 
(a) Kaplan-Meier analysis of alopecia-free and overall survival in TCR3 retrogenic 
mice. (b) The dorsal surface of a representative TCR3 mouse demonstrates extensive 
alopecia areata. (c) Premature catagen and inflammatory infiltrates in the follicular and 
interfollicular epidermis, and inflammatory infiltrates associated with diffuse thickening 
and hypercellularity of the squamous esophageal epithelium of a day 30 TCR3 mouse. 
Immunohistochemistry for CD3
+
 cells demonstrates markedly increased T cell numbers 
compared with a healthy control (CTRL) retrogenic mouse.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 54 
TCR, or the 4 group 2 TCR that were identified in a single CNS but public in the 
spleen. Mice expressing the 5 private group 3 TCR were also absent of clinical or 
histologic disease (Figure 3-16). 
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Figure 3-16. MOG35-55 response and disease-free survival of retrogenic mice. 
MOG35-55 specific proliferation, disease-free survival, and overall survival is plotted for 
group 1 (TCR1-6), group 2 (TCR 7-10), and group 3 (TCR 11-15) mice not 
otherwise shown in other figures. (a) T cell proliferation to MOG35-55. CD4
+
 T cells were 
purified from splenocytes from the indicated disease-free retrogenic mice and cultured 
for 3 days in the presence of syngeneic irradiated splenic APCs in the absence of 
additional stimulation or with 100 g ml-1 MOG35-55 or CD3/CD28. Cultures were 
pulsed with 
3
H-thymidine at 72 hr and 
3
H incorporation measured. Circles indicate means 
of triplicates from individual mice. No significant differences were identified between 
unstimulated and MOG35-55 stimulated samples for the mice shown. (b) Kaplan Meier 
analysis of disease free and overall survival of the indicated retrogenic mice is shown. 
Disease-free and overall survival was 100% over the 120 day observation period for all 
mice plotted except TCR10, of which 2 died without overt preceding illness or apparent 
cause. 
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CHAPTER 4.    PRELIMINARY EXPERIMENTS 
 
 
Introduction 
 
 Though TCR repertoire analysis has proved to be powerful tool in investigate the 
relationship between Treg and Tconv cells, the disparity of the results conducted from 
those experiments were affected by different mice model and sample size of the TCR 
repertoire, and it is limited in that inferences are made by population shifts in the absence 
of knowledge about antigen specificity. To better clarify the relationship between Treg 
cells and Tconv cells, the best way is to study the specificity and responsiveness of Treg 
and Tconv in the context of specific antigens. Our lab developed a retrogenic mouse 
model of EAE in which the TCR chain locus was fixed by the enforced expression of a 
TCR from a myelin oligodendrocyte glycoprotein (MOG)-specific T cell. TRBV13-2 is 
expressed by almost half of MOG-specific T cells in MOG-EAE, and we focused on this 
disease-associated repertoire
101
.  
 
However, as we discussed in Chapter 3, public TCR distort repertoire response 
characteristics and foster reactivity to specific autoantigens. We can benefit from 
retrogenic mice models with enforced expression diseased associated public TCRchains 
and investigate the Tconv and Treg TCR repertoires. To begin with, we will focus on the 
TCR1 retrogenic mice for several reasons. First, it is the most commonly shared TCR1 
in immunized mice and pre-immune mice. Second, it is presented on both Treg and 
Tconv population, narrowing our TCR fine specificity analysis on the paring 
TCRrepertoire. Third, TCRβ1 mice develop spontaneous EAE by imposing a high 
frequency of MOG-reactive TCR repertoire, implying the close association between 
TCRβ1 derived repertoire with MOG-EAE.  
 
 
Results 
 
We favor a model where the public TCRβ1‚ which pairs with degenerate TCRα 
but still retains auto-reactivity, however, we cannot rule out the possibility that this public 
TCRβ1 may impose a biased TCRα paring. Biased TCRα usage was observed on CNS 
infiltrating cells in MOG-EAE mice, V9-J23 and V9-J31. However, there lacks 
evidence to show whether this biased TCRα usage is TCRβ1 related126.  
 
First we need to identify the TCR repertoire in TCRβ1 retrogenic mice. Mice 
were sacrificed around day 30 post bone marrow transplant during their peak disease, and 
CNS T cells were isolated. The number of specific Vα antibodies are very limited, only 
Vα 2, Vα3.2, Vα5, Vα8.3 and Vα11 specific antibodies are commercialized. Flow 
cytometric phenotyping of the isolated CNS T cells by using these Vα antibodies failed to 
show any enriched TRAV usage compared with MOG-induced EAE mice (data not 
shown). Since Vα nucleotide sequences are much more conservative than Vto 
discriminate different Vα subtype, full length TCRα cDNA were generated by using 5’ 
RACE. CNS infiltrating T cells from TCRβ1 were sorted into Treg and Tconv population. 
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cDNA were synthesized, amplified by using 21 Vα and Cα specific primers, and TA 
subcloned into the pCR2.1 vector to create a cDNA library of TCRα chains. cDNA 
containing plasmids will be randomly selected and sequenced. Vα, Jα, and CDR3α 
regions will be interpreted by IMGT-V-QUEST (http://imgt.cines.fr). 
 
Overall, 52 unique TCRα chains were identified from three mice (Table 3-6), 
among which 29 were Tconv derived whereas 23 were Treg derived. The CDR3 
sequences of those oligoclone types were heterogeneous and did not overlap between 
mice, indicating that TCR1 is associated with diverse TCR. However, TRAV4 and 
TRAV7 utilization were enriched in either Foxp3- Tconv cells (TRAV4: 17%, TRAV7: 
35%) or Foxp3+ Treg cells (TRAV4: 48%, TRAV7: 26%), but we didn’t find any 
evident enriched TRBJ usage (Figure 4-1). 
 
Though we identified a number of TCRα from TCR1 CNS infiltrating cells, and 
TCR1 was able to impose TCR MOG35-55 reactivity by paring with degenerate TCRα, 
however, what antigen these T cells recognized in vivo was still unknown. They can be 
either a MOG responder, a MOG non-responder but react to other cryptic self-antigen in 
CNS
138
, or a just circulating bystander during the CNS inflammation. Therefore we fist 
tested their MOG35-55 specificity in CD4 4G4 hybridoma T cell lines. Fourteen out of 
fifty-two TCR reconstituted hybridoma cell lines demonstrated low to high MOG35-55 
reactivity (Table 4-1). Next, we further tested their fine specificity of all MOG35-55 
reactive TCR in peptide titration assay. In either Treg or Tconv population, TCR were 
identified with high, moderate, and low sensitivity for MOG35-55 stimulation (Figure 4-2). 
Nine out of eleven TCR with TRAV4 V region mediated moderate to high MOG35-55 
response, no matter it was Treg or Tconv derived. In contrast, the other 2 TRAV4 TCR 
were able to mediate very low MOG35-55 response, both of which were Treg derived. In 
addition, 2 TRAV7 TCR mediated low to moderate MOG35-55 response, both of which 
were Tconv derived. The only 1 TRACV13 TCR mediated high MOG35-55 response, and 
it was from Tconv. 
 
To find out whether MOG35-55 specificity in vitro was correlated with the 
pathogenesis in vivo, retrogenic mice were made with enforced expression of particular 
MOG35-55 specific TCRMice were followed for disease development for at least 80 
days post bone marrow transfer. For most of the Tconv derived TCR (Figure 4-3a), mice 
progressed spontaneous EAE symptoms with early T cell engraftment, only PUN308 was 
observed for decreased incidents due to its poor engraftment. For those Treg derived TCR 
(Figure 4-3b), PUN342 could induce severe spontaneous EAE, but Br11, Br17, Br25, 
Br41, Br47 were observed with sporadic or no disease incidents which were associated 
with low T cell engraftment. For PUN355 and PUN376, those TCRs showed low MOG35-
55 reactivity, no disease was observed even with good engraftments. 
 
From these preliminary experiments, it seems impossible to simply correlate any 
TRAV usage, T cell type, CDR3sequences or MOG35-55 specificity with pathogenesis 
in vivo. PUN003 and PUN005 were Tconv derived with low MOG reactivity, but were 
still able to induce spontaneous EAE otherwise high MOG reactive PUN308 was on the  
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Figure 4-1. Pie charts of TRAV and TRAJ usage in TCRCNS infiltrating T 
cells. 
CNS infiltrating T cells were isolated from TCR retrogenic mice. cDNA was 
synthesized, subcloned, and followed by Sanger sequencing (a) TRAV usage in Tconv or 
Treg (b) TRAJ usage in Tconv or Treg. 
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Table 4-1. Fourteen reconstituted TCRwith MOG35-55 reactivity on hybridoma cells. 
 
Constructs Derived 
cell type 
TRAV TRAJ CDR3α TRBV TRBJ CDR3β 
PUN002 Foxp3
-
 TRAV4D-3 TRAJ21 AAGGYNVLYF TRBV13-2 TRBJ2-1 ASGETGGNYAEQF 
PUN003 Foxp3
-
 TRAV7-3  TRAJ27 AANTGKLTF TRBV13-2 TRBJ2-1 ASGETGGNYAEQF 
PUN005 Foxp3
-
 TRAV7D-3 TRAJ37 AVGGNTGKLIF TRBV13-2 TRBJ2-1 ASGETGGNYAEQF 
PUN307 Foxp3
-
 TRAV4D-4 TRAJ42 AASGGSNAKLTF TRBV13-2 TRBJ2-1 ASGETGGNYAEQF 
PUN308 Foxp3
-
 TRAV4D-3 TRAJ49 AAVTGYQNFYF TRBV13-2 TRBJ2-1 ASGETGGNYAEQF 
PUN323 Foxp3
-
 TRAV13D-1 TRAJ37 ALITGNTGKLIF TRBV13-2 TRBJ2-1 ASGETGGNYAEQF 
PUN342 Foxp3
+
 TRAV4D-3 TRAJ42 AAGGSNAKLTF TRBV13-2 TRBJ2-1 ASGETGGNYAEQF 
PUN355 Foxp3
+
 TRAV4D-4 TRAJ57 AAGQGGSAKLIF TRBV13-2 TRBJ2-1 ASGETGGNYAEQF 
PUN376 Foxp3
+
 TRAV4D-3 TRAJ50 AARSSSSFSKLVF TRBV13-2 TRBJ2-1 ASGETGGNYAEQF 
BR11 Foxp3
+
 TRAV4D-3 TRAJ33  AAPDSNYQLIW TRBV13-2 TRBJ2-1 ASGETGGNYAEQF 
BR17 Foxp3
+
 TRAV4D-3 TRAJ57 AARQGGSAELIF TRBV13-2 TRBJ2-1 ASGETGGNYAEQF 
BR25 Foxp3
+
 TRAV4D-3 TRAJ40 AAPGNYKYVF TRBV13-2 TRBJ2-1 ASGETGGNYAEQF 
BR41 Foxp3
+
 TRAV4D-3 TRAJ39 AAGGDNAGAKLTF TRBV13-2 TRBJ2-1 ASGETGGNYAEQF 
BR47 Foxp3
+
 TRAV4D-3 TRAJ50 AAIASSSFSKLVF TRBV13-2 TRBJ2-1 ASGETGGNYAEQF 
Identified TCR sequences from 5’ RACE were reconstituted with TCR1 and transduced into CD4 4G4 hybridoma cells. All the 
hybridoma cell lines were treated with 100ug/ml MOG35-55 in the presence of syngeneic APCs.  IL-2 production was measured by 
ELISA at 24 hr. Fourteen out of total fifty-two unique TCR chains were further tested for their fine specificity.  
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Figure 4-2. Titration assay for MOG35-55-specific TCR. 
TCR reconstituted 4G4 CD4 hybridoma cells were tested for their fine specificity to 
MOG35-55 stimulation in vitro. IL-2 production was analyzed by ELISA assay for 
different cell lines bearing either Tconv (a) or Treg (b) T-cell derived TCR, stimulated 
with varied doses of MOG35-55 peptide in the presence of syngeneic APCs. PUN342 line 
is Treg derived TCR, used as an inner control for comparability. Data shown is 
representative of 3 independent experiments with at least 2 independent transductions of 
each TCR. 
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Figure 4-3. MOG35-55 response and disease-free survival of TCR retrogenic 
mice.  
Kaplan Meier analysis of disease free of the indicated TCR retrogenic mice is shown. 
TCRwas enforced expression with different TCRidentified from 5’RACE. Disease 
development was followed in these retrogenic mice at least 80 days post bone marrow 
transfer. Sick mice were sacrificed and analyzed before moribund. (a) Retrogenic mice 
with Tconv derived TCRb) Retrogenic mice with Treg derived TCRData was 
collected from at least 2 batches of retrogenic mice. Total mice number was indicated. 
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opposite, indicating it was not a solely MOG35-55 specificity dependent pattern. The 
situation seems more complicated for Treg derived TCR, high MOG reactive PUN342 
could induce disease while low MOG reactive PUN355 and PUN376 could not, even 
though PUN342 possess Tregs during the early disease (4.47±4.24% in CNS, 7.70±7.74% 
in Spleen). On the other hand, several other Treg derived TCRs (Br11, Br17, Br25, Br41, 
Br47) were observed with poor early T cell engraftment resulting in the sporadic or no 
disease incidents. Interestingly, we noticed the CDR3 sequences of PUN342 and 
PUN307 are almost identical except one extra “S” residue on the 3rd position of PUN342. 
They were identified from distinct T cell population, however, both of them share similar 
MOG35-55 specificity and pathogenesis. This “S” residue can be tolerated due to the 
degeneracy of TCR specificity against MOG35-55-MHC ligand, but it may provide some 
clues for T cell lineage commitment in the thymus. 
 
Retrogenic mice developed spontaneous EAE around day 30 post bone marrow 
transfer, for which early engraftment of those MOG35-55 specific T cells seems essential 
for disease onset
123
. To investigate the relationship between early engraftment level and 
disease, the data from retrogenic mice of Tconv derived TCRwere pooled together, 
and disease onset day showed an inverse correlation against the CD4 T cell frequency in 
blood lymphocytes on day 28, the higher level CD4 T cell frequency, the earlier the 
disease (Figure 4-4). Treg derived TCR was not analyzed here because only PUN342 
developed disease with detected level of engraftment. Therefore the data was limited for 
Treg derived TCR. 
 
Treg derived TCR would generate Tregs in retrogenic mice, whereas there was 
not Treg cells in retrogenic mice expressing Tconv derived TCR
123
. Overlaid on this, 
retrogenic mice with PUN342, which was identified from a Treg clonotype, still 
developed severe spontaneous EAE with early T cell engraftment. Phenotypic analysis 
were routinely performed on the retrogenic mice during their peak disease, a proportion 
of Tregs was present in PUN342 retrogenic mice (Spleen: 7.7±7.7%; CNS: 4.7±4.2%) 
and the absolute Treg cell number was Spleen: 4.1±5.3x10
4
 CNS:1.3±1.2x10
4
. However, 
the disease seems not to be protected in the presence of this small fraction of Tregs. 
 
There was also a low frequency of Tregs in the PUN308 retrogenic mice, but the 
actual number was very limited. This might result from the background noise for flow 
cytometry in retrogenic mice if the mice were poorly engrafted. There were very limited 
Treg cells in the spleen of retrogenic mice expressing Tconv derived TCRs, which was 
consistent with prior reports
123,139
. However, in some cases, a small number of Foxp3
+
 
CD4
+
 T cells were observed in CNS. Those CNS Foxp3
+
 T cells might be expanded 
nTreg or induced Treg responding to abundant antigenic stimulation (Figure 4-5). 
 
Since the retrogenic mice develop spontaneous EAE with very early T cell 
engraftment at ~4 wk, characterization of the mechanism undergoing during that time 
point maybe suggestive. What antigens are those cells recognizing? Whether they are 
antoantigens or foreign antigens? Why those activated T cells can migrate into CNS? The 
commensal bacteria is associated with CNS disease
140,141
, so our first intuition was that 
TCR cross-reactivity to the commensal microbial antigens stimulated the T cells. Then  
 65 
 
 
Figure 4-4. Disease onset is associated with early CD4 T cell engraftment. 
Retrogenic mice were analyzed for CD4 T cell engraftment on day 28 post bone marrow 
transfer. These engraftment data of Tconv derived TCR was pooled together and the 
frequency of CD4 T cells gating in blood lymphocytes was plotted against disease onset 
day, showing an inverse correlation pattern. 
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Figure 4-5. Treg analysis of retrogenic T cells.  
Flow cytometric analysis of surface-stained splenocytes from the indicated type of 
retrogenic mouse is shown. Mice were sacrificed and analyzed during their peak disease 
(disease score >3) (a) Frequency of Tregs either in spleen or CNS CD4 T lymphocyte 
population. (b) Cellularity of Tregs either in spleen or CNS. 
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we tried to test the responsiveness of four MOG35-55 specific TCR to MOG35-55 mimicry 
peptides. They are PUN002 (Tconv, high MOG35-55 reactivity), PUN003 (Tconv, 
moderate MOG35-55 reactivity), PUN003 (Tconv, low MOG35-55 reactivity) and PUN342 
(Treg, high MOG35-55 reactivity). Though different TCR demonstrated variability, the 
common patterns of reactivity when tested with alanine-substituted MOG35-55 peptides 
were quite similar (Figure 4-6). Similar to prior studies characterizing the R41, F44, 
R46, and V47 are critical MOG35-55 residues for specific TCR interacting
142
, stimulation 
with common patterns of reactivity when tested with alanine-substituted MOG35-55 
peptides alanine-substituted peptides such as F44A, R46A, V47A and V48A greatly blunt 
the reactivity compared to original MOG35-55 peptide (Figure 4-6). These residues are 
determinants for epitope specificity at least for these four TCR clonotypes, however, the 
tolerance of TCR specificity to other alanine-substituted MOG35-55peptides suggests the 
potential cross reactivity of the MOG35-55 reactive T cells responding to the MOG35-55 
peptide mimicry. Since the experimental mice were conducted under specific germ free 
condition, the mimicry peptides may be introduced from the commensal bacteria, and 
lead to activation of the early engrafted MOG35-55 reactive T cells. 
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Figure 4-6. Cross reactivity to MOG35-55 mimicry. 
Four different 4G4 CD4 cell lines transduced with TCRwere tested for their 
responsiveness to 100μg/ml MOG35-55 or MOG35-55 mimicry peptides by ELISA.  The IL-
2 production was normalized to MOG35-55 group. Bars indicate from left to right IL-2 
production by clonotype PUN002, PUN003, PUN005 and PUN342. Dashed line was an 
indicator for MOG35-55. Mean ±SD is plotted. 
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CHAPTER 5.    DISCUSSION 
 
 
Public TCR in Skewing Repertoire Response and Autoimmune Susceptibility 
 
In previous chapters, we talked about by linking saturation sequencing of disease-
associated and unassociated repertoires during EAE with the transgenic expression and in 
vivo functional analysis of 15 public and private TCR, we identify a selective and 
prominent role of public TCR in the autoimmune response. Public TCR were 
preferentially incorporated into the CNS-infiltrating repertoire. The frequency of unique 
and total public TCR was markedly elevated when compared with TCR unengaged in 
autoimmunity both from mice with EAE and from pre-immune mice. Three public but no 
private TCR were able to confer unprimed T cells expressing endogenously rearranged 
TCR with overt MOG-reactivity. Enforced expression of two of six CNS-shared TCR 
provoked spontaneous autoimmunity in a mouse strain that does not otherwise develop 
spontaneous autoreactivity. Our findings indicate that public TCR distort repertoire 
response characteristics and foster reactivity to specific autoantigens. 
 
Recombinatorial biases in preselection thymocytes serve as the primary source for 
the generation of the broad public repertoire
42,143-145
. Predispositions in VDJ usage and 
activity levels of TdT and nucleases modifying junctional sequences increase the 
probability these sequences will form
146
. We implicate similar pre-selection biases in also 
generating the public autoimmune repertoire, and identify substantial ongoing oligoclonal 
production of public autoimmune-associated TCR within the thymus. As previously 
documented by Dyson and colleagues with the larger public repertoire
147
, analyses of the 
frequency of individual receptors in pre- and post-selection thymocytes and splenic T 
cells further failed to indicate that, once formed, disease associated public TCR are 
preferentially selected (data not shown).  
 
Our results do not imply that public TCR possess unique structural properties that 
distinguish them from private TCR. Indeed, despite comprising a small fraction of the 
total repertoire, public sequences remain diverse. It would therefore seem unlikely that 
their preferential recruitment into the autoimmune response when compared with private 
sequences is due to a distinct biochemistry. Rather, because public TCR are pervasive 
across a population, specificity distortions they introduce within the repertoire will be 
introduced into all individuals bearing relevant MHC alleles. Thus, MOG35-55 may serve 
as the dominant autoantigen in C57BL/6 EAE precisely because the public repertoire in 
conjunction with the restricting MHC, IA
b
, augments repertoire reactivity toward this 
autoantigen. Other neuroantigens preferentially engaged by private TCR would only be 
capable of mediating autoimmunity in the small number of individuals that stochastically 
possess adequate numbers and subsets of antigen-specific private T cells. 
 
An alternative hypothesis for the preferential incorporation of public sequences in 
the autoimmune repertoire is that these sequences do predispose TCR toward self-
reactivity. Other repertoire studies, though more limited in scope and definition compared 
with these, have also identified public sequences among autoreactive T cells
123,125,148
. 
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That public TCR may more generically confer responsiveness to self-antigens is also 
suggested by our finding that transgenic expression of the public, EAE-associated TCR3 
chain led to the development of spontaneous alopecia areata and not EAE. Therefore, a 
single TCR may promote reactivity to disease-associated autoantigens from different 
tissues. In this regards, it is noteworthy that a previously isolated though distinct 
TRBV13-2
+
 TCR from a MOG35-55-specific hybridoma, 1MOG244.2, was identified as 
possessing two TCR chains. Transgenic expression of one TCR led to MOG35-55 
reactive T cells. The second provoked spontaneous alopecia areata, suggesting a broader 
association between CNS and skin reactivities
149
. 
 
Public TCR use is not only identifiable in the context of autoimmunity, but has 
also been found in the responses to several pathogens and other antigens
42,127
. One 
possible explanation is that the recombinatorial activities involved in forming the public 
repertoire also creates a public sequence space that more broadly supports TCR 
associations with MHC-antigen complexes. The majority of the TCR interface with 
antigen-MHC binds the MHC rather than antigenic peptide, and MHC-specific 
associations are critical to stabilizing this interaction
6,150
. If the public repertoire 
incorporates TCR better suited to support MHC engagement, these receptors may 
preferentially enter immune responses. Such a model would suggest a co-evolution of the 
public TCR repertoire with restricting MHC, presumably by modulating recombination 
frequencies so as to optimize this component of the response. An element of enhanced 
self-reactivity would be expected to accompany such increased TCR fitness. Indeed, TCR 
mutations that enhance TCR-MHC association also promote self-reactivity and can 
endow TCR with new autoreactivities
151,152
. 
 
We found that 2 of the 6 group 1 (CNS-shared and public) TCR and altogether 3 
shared TCR broadly imposed MOG specificity on TCR. MOG-responsiveness was 
particularly prominent in mice expressing TCR1, where nearly 1/3 the number of CD4+ 
T cells from disease-free animals responding to CD3 proliferated to MOG35-55. Unlike 
antibody-antigen interactions, which may rely on a single Ig chain, the TCR-MHC 
interface extensively involves both the TCR and  surfaces. Implicitly, TCR1 
dominates interactions defining specificity during MOG35-55-IA
b
 recognition, and this is 
accompanied by more generic interactions with TCR that are simply non-disruptive and 
provide requisite supplemental association energy for effective T cell stimulation. 
However, in the absence of structural definition, it cannot be excluded that TCR1 and 
other public TCR chains bind autoantigens in non-conventional manners that minimize 
reliance on the TCR. 
 
The capacity to interrogate the repertoire continues to increase with improving 
sequencing technologies
26
. Data sets are being collected in several disease models and 
these may be linked to functional analyses of individual TCR, similar to those we 
describe here, to identify the relevance of specific sequences. Indeed, the identification of 
preferential TRBV and TRAV usage in several diseases may imply that public TCR or 
TCR sequences bearing pre-defined V, J, and CDR3 sequences will strongly skew 
response characteristics. If so, specific public sequences may prove useful for the 
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longitudinal monitoring of immune responses during autoimmune diseases. Likewise if 
public TCR ultimately prove not only to be over-represented and risk factors for the 
autoimmune response as indicated here, but drivers of it as originally hypothesized by 
Sercaz and colleagues
153
, it may be possible to broadly modulate the autoimmune 
response by specifically guiding the selection or activity of T cells bearing public TCR 
sequences. 
 
 
Functional Characterization of TCR Repertoire in TCR1 Retrogenic Mice Model 
 
Meanwhile, we performed preliminary experiments to characterize the 
TCRrepertoire by using the TCR1 mice model, which generated narrowed repertoire 
diversity with fixed TCR1 paring with endogenous TCRWe favor this mice model 
for the following consideration. First, it is the most commonly shared TCR in 
immunized mice and pre-immune mice. Second, it is presented on both Treg and Tconv 
population, narrowing our TCR fine specificity analysis on the paring TCRrepertoire. 
Third, TCRβ1 mice develop spontaneous EAE by imposing a high frequency of MOG-
reactive TCR repertoire, implying the close association between TCRβ1 derived 
repertoire with MOG-EAE. Investigation on the composition of TCR chain repertoire 
will potentially yield valuable information for the TCR structural features, specificity, 
responsiveness, and lineage commitment of Treg and Tconv in the context of 
autoimmune disease. 
 
We were able to identify 52 unique clonotypes from CNS of 3 TCR1 retrogenic 
mice. Though only a small number, these clonotypes were heterogeneous and did not 
overlap between mice, indicating that TCR1 can associate with diverse TCR. TCR 
were reconstituted and transduced into 4G4 CD4 hybridoma cells for MOG35-55 reactivity 
test in vitro. Fourteen unique TCR showed low to high responses to MOG35-55 stimulation.  
In order to investigate their potential pathogenesis against autoantigen in retrogenic mice, 
we made retrogenic mice which express single TCR. All the Tconv derived TCR were 
able to promote early spontaneous EAE, which seemed irrelevant to MOG specificity. 
However, PUN342, a Treg derived TCR with high MOG35-55 reactivity, promoted early 
spontaneous EAE even in the presence of Treg cells. While PUN355 and PUN376, Treg 
derived TCR with low MOG35-55 reactivity, failed to promote any disease. This result 
implicated that the presence of Treg cells were not able to protect the EAE induced by the 
high MOG35-55 reactive T cells. Meanwhile, some retrogenic mice expressing PUN308 
and several Treg derived TCRs (Br11, Br17, Br25, Br41, Br47) were noticed with poor 
engraftment. A possible explanation would be that these TCR clonotypes under the 
surveillance of central tolerance might hardly leak into the periphery. In C57BL/6 mice, 
Delarasse et al. have shown that MOG transcripts are expressed in thymus
154
. 
Nevertheless, the expression of MOG protein in human and mouse thymus has never 
been reported so far. Therefore, the MOG specificity of clonotypes may not simply 
correlated with the pathogenesis. Interestingly, we noticed that CDR3 sequences of two 
clonotypes are similar except one additional “S” residue on the 3rd position of Treg 
derived TCR. They are belonging to distinct T cell type, but sharing similar MOG 
specificity and pathogenesis. This “S” residue can be tolerated due to the degeneracy of 
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TCR specificity against MOG35-55-MHC ligand, but it seems critical for T cell lineage 
commitment in the thymus. Due to the limited number and poor engraftment capability of 
some TCR clonotypes, it is too early to come to any final conclusion that how fine 
specificity of TCR is relevant to T cell commitment or pathogenesis. 
 
 
Cross Reactivity, Gut and CNS 
 
Since the retrogenic mice develop spontaneous EAE with very early T cell 
engraftment, we are curious about what stimuli are recognized by those cells in vivo. We 
examined the responsiveness of four MOG reactive TCR to MOG35-55 mimicry peptides. 
Different TCR demonstrated variability, but common patterns of reactivity when tested 
with alanine-substituted MOG35-55 peptides was evident. MOG35-55 mimicry peptides such 
as F44A, R46A, V47A and V48A greatly blunted the reactivity compared to MOG35-55 
stimulation, suggesting that these residues are critical to sustain the specificity of the 
MOG35-55 peptide. Alternatively speaking, it may allow MOG35-55 -specific T cells to 
cross-react to various MOG35-55 mimicry peptides with these four critical residues 
unchanged. Here we propose these MOG35-55 mimicry peptide may come from the 
antigens of commensal bacteria. 
 
Due to the large number of clonotypically unique TCRs that can be generated by 
V(D)J somatic recombination, it was initially believed that the immune system might be 
capable of generating a TCR repertoire for virtually every antigenic peptide. However, 
subsequent estimates of the size of the peptide pool recognized by TCRs revealed that 
potentially immunogenic peptides in the environment of an individual greatly outnumber 
the amount of T cells. Each T-cell is estimated to react with >10
6
 different MHC-
associated peptide epitopes
155
, for which the concept of TCR cross-reactivity has been 
evoked as an essential mechanism to expand the effective size of the TCR 
repertoire
156,157
. However, the degeneracy of TCR specificity will increase the pathogenic 
potential T cells as it augments the likelihood of self-pMHC recognition. Indeed, several 
studies have reported that TCR cross-reactivity and molecular mimicry is associated with 
autoimmune disease, whereby the viral or bacterial peptides mimic autoantigens and 
provoke the autoimmunity
158,159
. Moreover, structural studies provided substantial 
evidence to reveal the recognition features of several autoreactive TCR-pMHC 
complexes
151,160-164
. These features were summarized as altered TCR docking topologies, 
paucity of hydrogen bonds between the TCR and self-peptide, peptide recognition by the 
CDR3 loops alone, limited interactions between the TCR and MHC, suboptimal fit of the 
self-peptide in the MHC binding groove and partial occupancy of the groove by the self-
peptide
141
. What these cross-reactive TCR actually recognize in vivo is unknown.  Since 
the mammalian gastrointestinal track can harbor a highly heterogeneous microbial 
population comprising over 1x10
13
-10
14
 resident bacteria, commensal bacteria may 
provide the most abundant foreign antigens that may mimic autoantigens in vivo. 
Evidence has demonstrated the relationship between CNS demyelinating diseases and 
commensal bacteria. For instance, in EAE mice model, alteration of the bacterial 
populations of the gut has been demonstrated to alter the clinical outcome
165
. Oral 
administration of antibiotics protected against EAE
166
. 
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Based on this hypothesis, we proposed that microbial antigens may take 
advantage of the similar molecular mimicries and activate the early engrafted retrogenic 
T cells in the periphery. To test that in our pilot experiments, we were able to continually 
treat our retrogenic mice with combined antibiotics. Those mice were either enforced 
expressing fixed TCR chain (TCR1, TCR3) or enforced expressing single 
TCR(PUN342). The autoimmune disease was completely prevented (Nguyen, 
unpublished data). Retrogenic mice of control group were treated with syrup only, they 
still developed spontaneous autoimmune disease and a substantial number of highly 
activated CD4 T cells could be isolated from gut tissue and the mesenteric lymph nodes 
(Nguyen, unpublished data). 
 
In order to further clarify the mechanism, future experiments are necessary to 
screen out the bacteria and the bacterial antigen if possible. Admittedly, the variation in 
intestinal microbiota communities of the laboratory mice is dependent on the 
environmental factors at each institutional facility. To circumvent this problem, germ-free 
mice line is necessary to identify the association among the gut-microbiota antigen and 
the CNS demyelinating diseases. 
 
 
Retrogenic Mice Models versus Transgenic Mice Models 
 
TCR transgenic mice are widely used and have had a large in current 
immunological research. Several studies focusing on TCR repertoire analyses also 
successfully utilized transgenic mice enforced the TCR chain with or without a TCR 
chain minilocus
97,100
. This approach is much stable and natural since the T cell first 
develop in the neonatal condition, but it is time consuming and costly, needs careful pre-
experiment design. Due to the time and cost inconvenience, this approach doesn’t fit a 
comprehensive functional assessment of multiple public TCRβs. 
 
To circumvent these problems, we utilized another commonly used mice model, 
retrogenic mice, in which specific TCRs were retrovirally transduced into hematopoietic 
stem cells
136
. This approach is substantially faster than making trangegnic mice, (6 weeks 
versus 6 months), making a comprehensive functional assessment of multiple public 
TCRβs possible. Compared with transgenic mice, there still exists some disadvantage, 
such as less T lymphocytes, laborious effort to generate each mouse, unnatural phenotype 
of peripheral T cells with an increased memory-like phenotype in a lymphopenic host 
condition. In addition, we sublethally irradiated recipient mice to facilitate stem cell 
engraftment, and how sublethal irradiation itself may affect the mice is hard to judge. 
Furthermore, bone marrow transfer is required for making retrogenic mice model, the 
more steps for manipulation, the more risk to expose to environmental antigens, meaning 
studies about the spontaneous disease imposed by public TCR chains in germ free 
condition is difficult. 
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Admittedly, although we have not seen any deleterious consequences per se, these 
effects can potentially influence experimental results and should be considered in 
interpreting data from the system. 
 
 
Summary 
 
In summary, in this project, we were able to couple the high-throughput 
sequencing of the TCR repertoire in EAE mice model, with functional studies 
demonstrating the role of public TCR chains in disease susceptibility in retrogenic mice. 
Analyses of >18 million TCR from Foxp3+ regulatory and Foxp3- conventional T cells 
from different organs and time points, we identified a high prevalence of public TCR 
within the autoimmune response. The public TCR are more likely to be formed in pre-
selection thymocytes, which also reside in the pre immune repertoire and is preferentially 
employed in autoimmune responses, suggesting the hidden “foes” may impose disease 
risk once if the immune system is out of control. We also performed some pilot 
experiments by treating the retrogenic mice with antibiotics, thus the autoimmune 
diseases were totally protected, and suggesting the cross-reactivity towards the 
commensal microbial antigens might activate the retrogenic CD4 T dells in periphery. 
This experiment provides insights for the relationship between commensal bacteria and 
the CNS demyelinating diseases. Though the underlying mechanism and the particular 
antigens are not well understood, this study still provides a potential therapeutic insight. 
Coupling high-throughput immunosequencing, specific public sequences may prove useful 
for the longitudinal monitoring of immune responses during autoimmune diseases. 
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APPENDIX A. SUPPLEMENTAL TABLES 
 
 
Table A-1. Annealing oligo sequences for CDR3
 
 Oligo 5’ to 3’ nucleotide sequence 
TCR1 sense TCGAGTTGGCTACCCCCTCTCAGACATCAGTGTACTTCT
GTGCCAGCGGTGAGACTGGGGGAAACTATGCTGAGCAG
TTCTTCGGACCAGGGACACGACTCACCGTCCTAGAA 
anti-
sense 
GATCTTCTAGGACGGTGAGTCGTGTCCCTGGTCCGAAGA
ACTGCTCAGCATAGTTTCCCCCAGTCTCACCGCTGGCAC
AGAAGTACACTGATGTCTGAGAGGGGGTAGCCAAC 
TCR2 sense TCGAGTTGGCTACCCCCTCTCAGACATCAGTGTACTTCT
GTGCCAGCGGTGACAGGTATGAACAGTACTTCGGTCCC
GGCACCAGGCTCACGGTTTTAGAA 
anti-
sense 
GATCTTCTAAAACCGTGAGCCTGGTGCCGGGACCGAAG
TACTGTTCATACCTGTCACCGCTGGCACAGAAGTACACT
GATGTCTGAGAGGGGGTAGCCAACTCGAG 
TCR3 sense TCGAGTTGGCTACCCCCTCTCAGACATCAGTGTACTTCT
GTGCCAGCGGCTATGAACAGTACTTCGGTCCCGGCACCA
GGCTCACGGTTTTAGAAGATCT 
anti-
sense 
GATCTTCTAAAACCGTGAGCCTGGTGCCGGGACCGAAG
TACTGTTCATAGCCGCTGGCACAGAAGTACACTGATGTC
TGAGAGGGGGTAGCCAACTCGAG 
TCR4 sense TCGAGTTGGCTACCCCCTCTCAGACATCAGTGTACTTCT
GTGCCAGCGGTGAAACAGCAAACTCCGACTACACCTTC
GGCTCAGGGACCAGGCTTTTGGTAATAGAAGATCT 
anti-
sense 
GATCTTCTATTACCAAAAGCCTGGTCCCTGAGCCGAAGG
TGTAGTCGGAGTTTGCTGTTTCACCGCTGGCACAGAAGT
ACACTGATGTCTGAGAGGGGGTAGCCAACTCGAG 
TCR5 sense TCGAGTTGGCTACCCCCTCTCAGACATCAGTGTACTTCT
GTGCCAGCGGTGATGCTGGGGGGTCCTATGAACAGTAC
TTCGGTCCCGGCACCAGGCTCACGGTTTTAGAAGATCT 
anti-
sense 
GATCTTCTAAAACCGTGAGCCTGGTGCCGGGACCGAAG
TACTGTTCATAGGACCCCCCAGCATCACCGCTGGCACAG
AAGTACACTGATGTCTGAGAGGGGGTAGCCAACTCGAG 
TCR6 sense TCGAGTTGGCTACCCCCTCTCAGACATCAGTGTACTTCT
GTGCCAGCGGTGATGGTGAACAGTACTTCGGTCCCGGC
ACCAGGCTCACGGTTTTAGAAGATCT 
anti-
sense 
GATCTTCTAAAACCGTGAGCCTGGTGCCGGGACCGAAG
TACTGTTCACCATCACCGCTGGCACAGAAGTACACTGAT
GTCTGAGAGGGGGTAGCCAACTCGAG 
TCR7 sense TCGAGTTGGCTACCCCCTCTCAGACATCAGTGTACTTCT
GTGCCAGCGGTGAGCAACAGGGGACTGAGCAGTTCTTC
GGACCAGGGACACGACTCACCGTCCTAGAAGATCT 
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Table A-1. (Continued). 
 
 Oligo 5’ to 3’ nucleotide sequence 
 anti-
sense 
GATCTTCTAGGACGGTGAGTCGTGTCCCTGGTCCGAAGA
ACTGCTCAGTCCCCTGTTGCTCACCGCTGGCACAGAAGT
ACACTGATGTCTGAGAGGGGGTAGCCAACTCGAG 
TCR8 sense TCGAGTTGGCTACCCCCTCTCAGACATCAGTGTACTTCT
GTGCCAGCGGTGATGGACTGGGGGGCTCCTATGAGCAG
TACTTCGGTCCCGGCACCAGGCTCACGGTTTTAGAAGAT
CT 
 anti-
sense 
GATCTTCTAAAACCGTGAGCCTGGTGCCGGGACCGAAG
TACTGCTCATAGGAGCCCCCCAGTCCATCACCGCTGGCA
CAGAAGTACACTGATGTCTGAGAGGGGGTAGCCAACTC
GAG 
TCR9 sense TCGAGTTGGCTACCCCCTCTCAGACATCAGTGTACTTCT
GTGCCAGCGGTGATGTCCGGGGCTATAATTCGCCCCTCT
ACTTTGCGGCAGGCACCCGGCTCACTGTGACAGAAGAT
CT 
 anti-
sense 
GATCTTCTGTCACAGTGAGCCGGGTGCCTGCCGCAAAGT
AGAGGGGCGAATTATAGCCCCGGACATCACCGCTGGCA
CAGAAGTACACTGATGTCTGAGAGGGGGTAGCCAACTC
GAG 
TCR10 sense TCGAGTTGGCTACCCCCTCTCAGACATCAGTGTACTTCT
GTGCCAGCGGTGATGGAACATCAAACTCCGACTACACC
TTTGGGCCAGGCACTCGGCTCCTCGTGTTAGAAGATCT 
 anti-
sense 
GATCTTCTAACACGAGGAGCCGAGTGCCTGGCCCAAAG
GTGTAGTCGGAGTTTGATGTTCCATCACCGCTGGCACAG
AAGTACACTGATGTCTGAGAGGGGGTAGCCAACTCGAG 
TCR11 sense TCGAGTTGGCTACCCCCTCTCAGACATCAGTGTACTTCT
GTGCCAGCGGGATAGGGGACACCCAGTACTTTGGGCCA
GGCACTCGGCTCCTCGTGTTAGAAGATCT 
 anti-
sense 
GATCTTCTAACACGAGGAGCCGAGTGCCTGGCCCAAAG
TACTGGGTGTCCCCTATCCCGCTGGCACAGAAGTACACT
GATGTCTGAGAGGGGGTAGCCAACTCGAG 
TCR12 sense TCGAGTTGGCTACCCCCTCTCAGACATCAGTGTACTTCT
GTGCCAGCGGTGACGCCGGGACAGGGTATGAACAGTAC
TTCGGTCCCGGCACCAGGCTCACGGTTTTAGAAGATCT 
 anti-
sense 
GATCTTCTAAAACCGTGAGCCTGGTGCCGGGACCGAAG
TACTGTTCATACCCTGTCCCGGCGTCACCGCTGGCACAG
AAGTACACTGATGTCTGAGAGGGGGTAGCCAACTCGAG 
TCR13 sense TCGAGTTGGCTACCCCCTCTCAGACATCAGTGTACTTCT
GTGCCAGCGGGGACTGGGGGGGCGAAGACACCTTGTAC
TTTGGTGCGGGCACCCGACTATCGGTGCTAGAAGATCT 
 anti-
sense 
GATCTTCTAGCACCGATAGTCGGGTGCCCGCACCAAAGT
ACAAGGTGTCTTCGCCCCCCCAGTCCCCGCTGGCACAGA
AGTACACTGATGTCTGAGAGGGGGTAGCCAACTCGAG 
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Table A-1. (Continued). 
 
 Oligo 5’ to 3’ nucleotide sequence 
TCR14 sense TCGAGTTGGCTACCCCCTCTCAGACATCAGTGTACTTCT
GTGCCAGCGGTGATGAGACTGGGGGGGCCTATGAACAG
TACTTCGGTCCCGGCACCAGGCTCACGGTTTTAGAAGAT
CT 
anti-
sense 
GATCTTCTAAAACCGTGAGCCTGGTGCCGGGACCGAAG
TACTGTTCATAGGCCCCCCCAGTCTCATCACCGCTGGCA
CAGAAGTACACTGATGTCTGAGAGGGGGTAGCCAACTC
GAG 
TCR15 sense TCGAGTTGGCTACCCCCTCTCAGACATCAGTGTACTTCT
GTGCCAGCGGTGGGGGACTGGGGGGTACTAGTGCAGAA
ACGCTGTATTTTGGCTCAGGAACCAGACTGACTGTTCTC
GAAGATCT 
anti-
sense 
GATCTTCGAGAACAGTCAGTCTGGTTCCTGAGCCAAAAT
ACAGCGTTTCTGCACTAGTACCCCCCAGTCCCCCACCGC
TGGCACAGAAGTACACTGATGTCTGAGAGGGGGTAGCC
AACTCGAG 
Nucleotide sequences of sense and anti-sense oligos for 15 CDR3are listed. 
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APPENDIX B. SUPPLEMENTAL FIGURES 
 
 
 
 
Figure B-1. Diagram of two main plasmids. 
(a). MSCV-TCR1-GFP. (b). MSCV-244.2-TCR1-GFP 
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Figure B-2. Gating strategy for surface staining on TCR1 retrogenic mice. 
Cells were isolated from spleen and CNS and stained with specific antibodies. Flow 
cytometric analysis was performed on an LSRFortessa and analyzed by using FlowJo 
software. The cells were first gated on lymphocytes, gated out autofluorescent cells, 
doublets, and gated on CD4
+
TCR
+
 or CD8
+
TCR
+ 
lymphocytes. CD4
+
TCR
+
 lymphocytes 
were further analyzed based on their CD44 (memory/effector), CD45Rb (naïve), and 
CD69 (activation) markers. 
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Figure B-3. Gating strategy for Foxp3 intracellular staining on TCR1 retrogenic 
mice. 
Cells were isolated from spleen and CNS and stained with specific antibodies. Cells were 
first stained with surface markers, fixed, permeabilized and stained for intracellular 
Foxp3 with the Foxp3 Staining Buffer Set. The cells were first gated on lymphocytes, 
gated out autofluorescent cells, doublets, and gated on CD4
+
TCR
+
 lymphocytes. 
CD4
+
TCR
+
 lymphocytes were further analyzed based on their Foxp3 marker. 
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